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Summary 
The causes of intraocular inflammation are divided into 3 large groups namely infectious, non-
infectious and idiopathic. This research project set out to establish the prevalence of these 3 large 
groups and their different subgroups in an effort to determine whether HIV infection plays an 
important role in how frequently they occur in the Western Cape Province. 
Out of a total of 106 participants with uveitis enrolled in this study, 66 cases (62.3%) were HIV- and 
40 (37.7%) HIV+ with a median CD4+ cell count of 242 x 106/l. The majority of participants were 
black (n=52; 49.1%) or of mixed ethnicity (n=49; 46.2%) and 59.6% of blacks were HIV+ versus 16.3% 
of mixed ethnicity participants. Anatomically, most cases were either anterior uveitis (58.5%) or 
panuveitis (32.1%) while infectious uveitis (n=70; 66.0%) was more common than non-infectious 
(n=18; 17.0%) or idiopathic (n=18; 17.0%) uveitis. An infectious cause was found in 80.0% of HIV+ 
cases versus 57.6% in HIV- cases. 
Intraocular tuberculosis (IOTB) was the most common cause of infectious uveitis in this study (n=35; 
33.0%) where possible IOTB (n=23; 21.7%) was more common than probable IOTB (n=12; 11.3%). 
Tuberculin skin testing alone was more sensitive (90.3% vs 85.7%) and had a higher negative 
predictive value (92.1% vs 81.5%) than QuantiFERON alone and the latter therefore does not 
warrant the extra expense in our highly endemic setting. Herpetic uveitis formed the second largest 
group (n=13; 12.2%) with VZV (53.8%) responsible for more cases than CMV (38.5%) and HSV (7.7%). 
Syphilis was the third most common cause of infectious uveitis (n=11; 10.4%). Using a novel 
immunoblot approach the study investigated the relationship between ocular and neurosyphilis and 
demonstrated that these 2 conditions do not always co-exist. HIV infection was present in 31.4% of 
IOTB cases, 61.5% of herpetic cases and 81.8% of syphilitic cases. Toxoplasma (n=4; 3.8%), Rubella 
virus and poststreptococcal uveitis (n=3; 2.8% each) as well as HIV-induced uveitis (n=1; 0.9%) were 
responsible for the remainder of the infectious uveitis cases. EBV was often identified on multiplex 
PCR (n=11; 10.4%) but no evidence of active intraocular replication or antibody production was 
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found to prove that EBV caused uveitis in these cases. In most cases an alternative treatable cause of 
uveitis was identified (n=9; 81.8%). 
Sarcoidosis and HLA-B27 associated anterior uveitis (n=8; 7.5% each) were the most common causes 
of non-infectious uveitis. All patients with ocular sarcoid and 75% of patients with HLA-B27 uveitis 
were HIV-.  
The percentage of idiopathic cases in this study was lower than in many similar studies (n=18; 
17.0%). This is likely due to the high percentage of cases of possible IOTB diagnosed using a recently 
proposed classification as many of those cases would have been labelled as idiopathic in other 
studies. The majority of idiopathic uveitis cases were HIV- (n=12; 66.7%). 
This study revealed that infectious uveitis is the commonest form of uveitis in both HIV+ and HIV- 
patients but that the specific pathogens differ between patients with and without HIV infection. 
Opsomming 
Die oorsake van intraokulêre inflammasie word verdeel in 3 groot groepe naamlik infektief, non-
infektief en idiopaties. Die doel van hierdie navorsingsprojek was om die prevalensie van hierdie 3 
groepe asook hulle onderskeie subgroepe te bereken om te bepaal of HIV infeksie ‘n belangrike rol 
speel in hoe dikwels hulle in die Wes-Kaap provinsie voorkom. 
Uit ‘n totaal van 106 deelnemers aan hierdie studie was 66 gevalle (62.3%) HIV+ and 40 (37.7%) HIV- 
met ‘n mediane CD4+ seltelling van 242 x 106/l. Die meerderheid deelnemers was swart (n=52; 
49.1%) of van gemengde etniese afkoms (n=49; 46.2%) en 59.6% van swart deelnemers was HIV+ 
teenoor 16.3% van deelnemers van gemengde afkoms. Anatomies was die meeste gevalle anterior 
uveitis (58.5%) of panuveitis (32.1%) terwyl infektiewe uveitis (n=70; 66.0%) meer algemeen was as 
non-infektiewe (n=18; 17.0%) of idiopatiese (n=18; 17.0%) uveitis. ‘n Infektiewe oorsaak is gevind in 
80.0% van HIV+ gevalle teenoor 57.6% in HIV- gevalle. 
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Intraokulêre tuberkulose (IOTB) was die algemeenste oorsaak van infektiewe uveitis in hierdie studie 
(n=35; 33.0%) waar moontlike IOTB (n=23; 21.7%) meer algemeen was as waarskynlike IOTB (n=12; 
11.3%). ‘n Tuberkulien veltoets alleen was meer sensitief (90.3% vs 85.7%) en het ook ‘n hoër 
negatiewe voorspellende waarde (92.1% vs 81.5%) gehad as QuantiFERON alleen en laasgenoemde 
regverdig dus nie die addisionele finansiële uitgawe in hierdie hoogs endemiese gebied nie. 
Herpetiese uveitis was die tweede grootste groep (n=13; 12.2%) met VZV (53.8%) verantwoordelik 
vir meer gevalle as CMV (38.5%) en HSV (7.7%). Sifilis was die derde algemeenste oorsaak van 
infektiewe uveitis (n=11; 10.4%). Met behulp van ‘n nuwe immunoblot benadering is daar ondersoek 
ingestel na die verwantskap tussen okulêre sifilis en neurosifilis en is bewys dat dié 2 toestande nie 
altyd saam voorkom nie. HIV infeksie was teenwoordig in 31.4% van IOTB gevalle, 61.5% van 
herpetiese gevalle en 81.8% van sifilis gevalle. Toksoplasma (n=4; 3.8%), rubella-virus en 
poststreptokokkale uveitis (n=3; 2.8% elk) asook HIV-geinduseerde uveitis (n=1; 0.9%) was 
verantwoordelik vir die oorblywende infektiewe uveitis gevalle. EBV was dikwels teenwoordig op 
multipleks PKR (n=11; 10.4%) maar ons kon geen bewyse vind van aktiewe intraokulêre replikasie of 
teenliggaam produksie nie wat sou bewys dat EBV uveitis in hierdie gevalle veroorsaak het nie. In 
meeste gevalle is ‘n alternatiewe behandelbare oorsaak gevind (n=9; 81.8%). 
Sarkoiedose en HLA-B27 geassosieerde anterior uveitis (n=8; 7.5% elk) was die algemeenste oorsake 
van non-infektiewe uveitis. Al die pasiënte met okulêre sarkoiedose en 75% van pasiënte met HLA-
B27 uveitis was HIV-.  
Die persentasie idiopatiese gevalle in hierdie studie was laer as in baie soortgelyke studies (n=18; 
17.0%). Dit is waarskynlik as gevolg van die hoë persentasie gevalle met moontlike IOTB wat 
gediagnoseer is met ‘n onlangs gepubliseerde klassifikasie aangesien baie van daardie gevalle in 
ander studies as idiopaties beskou sou word. Die meerderheid idiopatiese gevalle was HIV- (n=12; 
66.7%). 
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Hierdie studie toon dat infektiewe uveitis algemeenste vorm van uveitis is in beide HIV+ en HIV- 
pasiënte maar dat die spesifieke patogene verskil tussen pasiënte met en sonder HIV infeksie. 
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Chapter 1: Introduction and literature review 
The term “uveitis” refers to inflammation of the uvea which is the vascular pigmented layer of the 
eyeball.  From anterior to posterior, this layer consists of the iris, the ciliary body and the choroid. 
Conditions causing inflammation of the uvea may also affect other intraocular structures such as the 
retina, the vitreous humor and the optic nerve which are anatomically not part of the uvea.1 In the 
ophthalmic literature, inflammation of the retina (retinitis), vitreous humor (vitritis) and optic nerve 
(optic neuritis) are often included under the umbrella term of uveitis although strictly speaking this 
is not accurate. The term “intraocular inflammation” would be preferable since it encompasses 
inflammation of any intraocular structures. It is, however, important to note that the terms “uveitis” 
and “intraocular inflammation” are often used interchangeably. 
Uveitis is classified according to the anatomical site(s) of inflammation inside the eye using the 
Standardization of Uveitis Nomenclature working group’s system from 2005.2 Uveitis may thus be 
classified as anterior, intermediate or posterior depending on where most of the inflammation is 
located. The term panuveitis is used when inflammation occurs throughout the eyeball. Based on 
clinical appearance, uveitis may also be subdivided into granulomatous or non-granulomatous.3 Even 
though the clinical picture does not always correlate perfectly with histopathological findings, this 
subdivision often provides a useful clue as to where to start searching for a cause of the condition. 
Uveitis is an important cause of ocular morbidity throughout the world. In Western countries, uveitis 
occurs in approximately 200 persons per 100 0004 with up to 35 % of patients suffering severe visual 
disability as a result.5 Between 5 and 10% of all cases of legal blindness in the United States and 
Europe are caused by uveitis.6 In developing countries, uveitis is even more common and occurred in 
1 out of every 140 persons (equivalent to 714 persons per 100 000) in a study from southern India.7 
Uveitis is also responsible for up to 25% of all blindness in these countries.8-10  
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The identifiable causes of uveitis may be divided into two main groups namely infectious and non-
infectious. However, a definite cause was previously only found in 65% of cases with the remainder 
being considered idiopathic.11 Due to recent improvements in the quality, quantity and availability of 
diagnostic modalities, the percentage of idiopathic cases is steadily decreasing. Infectious causes of 
uveitis such as tuberculosis and toxoplasmosis occur more commonly in developing countries while 
non-infectious causes such as sarcoidosis and HLA-B27 uveitis predominate in developed countries.12 
The prevalence of infectious and non-infectious causes of uveitis has to date not been 
comprehensively researched in South Africa with only 1 other research paper that appeared in 2016 
before the results of this study were published.13 It showed that uveitis was predominantly 
infectious in origin in the rural north-eastern corner of South Africa. 
A pilot study was conducted at Tygerberg Academic Hospital to review the role of polymerase chain 
reaction (PCR) testing of ocular fluid in identifying different herpes viruses as probable infectious 
causes of uveitis. The study also sought to determine whether HIV status affects PCR findings. Out of 
72 participants, 45.8% were HIV negative and 54.2% were HIV positive. PCR testing provided a 
positive result in 47.2% of cases and a significant correlation was found between a positive PCR yield 
and a positive HIV status (p=0.0018). Patients with posterior uveitis were also found to have a 
significantly increased PCR yield (p=0.014).14 This study laid part of the foundation for a much larger 
and more detailed research project to further investigate the different causes of intraocular 
inflammation in patients with and without HIV infection in the Western Cape. 
Non-infectious causes of uveitis 
Non-infectious causes of uveitis include the following conditions: sarcoidosis 15-17, HLA-B27 uveitis 18-
20, tubulo-interstitial nephritis and uveitis syndrome (TINU)21-24, sympathetic ophthalmia 25-28 , Vogt-
Koyanagi Harada  disease 29-31, Behcet’s syndrome 32-34, birdshot chorioretinopathy 35-37, serpiginous 
choroiditis 38,39, traumatic uveitis and lens-induced uveitis.40 These conditions have been studied 
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extensively in other parts of the world but the prevalence of these conditions in South Africa is 
unknown. 
Infectious causes of uveitis 
The infectious causes of uveitis may be subdivided into four large groups namely bacterial, viral, 
parasitic and fungal. An infectious aetiology is suspected in many idiopathic conditions but has not 
yet been proven conclusively. The prevalence of infectious causes of uveitis in South Africa was 
unknown until very recently. 
a) Bacterial causes 
Bacterial causes of uveitis include mycobacteria and spirochetes as well as gram-positive and gram-
negative bacteria. Mycobacterium tuberculosis41-43 and M leprae are examples of mycobacteria that 
may cause uveitis while Treponema pallidum44-47 and Borrelia burgdorferi48,49 are spirochetes known 
to cause uveitis. Uveitis due to gram-positive bacteria may form part of a poststreptococcal 
syndrome50,51 and gram-negative bacteria such as Tropheryma whippelii 52and Bartonella henselae 
53have also been proven to cause intraocular inflammation. Bacterial endophthalmitis may be 
caused by various gram-positive and gram-negative organisms.  
b) Viral causes 
Several different viruses are known to cause intraocular inflammation in humans. The majority of 
these viruses are herpesviridae which include herpes simplex virus 1 and 2 (HSV-1 and HSV-2)54-56, 
varicella-zoster virus (VZV)54,55, Epstein-Barr virus (EBV)57,58, cytomegalovirus (CMV)59-61 and human 
herpes virus 6 (HHV6)62,63. Rubella virus64-66 and HIV67,68 may both cause uveitis while lesser known 
viruses such as human parechovirus69 have also been proposed as possible causes of intraocular 
inflammation.  
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c) Parasitic causes 
Parasitic causes of intraocular inflammation in humans include Toxoplasma gondii70,71, Toxocara cati, 
Toxocara canis72and Oncocerca volvulus.73 Ocular toxoplasmosis is one of the commonest causes of 
retinochoroiditis worldwide but whether this is also the case in South Africa still needs to be 
determined.  
d) Fungal causes 
Many species of fungi are known to cause intraocular inflammation, especially endophthalmitis. The 
three main fungi implicated in this setting are Candida74-76, Aspergillus 75,76 and Cryptococcus75. 
Fungal endophthalmitis is a rare cause of intraocular inflammation but remains an important 
diagnosis to make since early treatment with specific anti-fungal agents can prevent extensive loss 
of vision. 
Finding the cause of intraocular inflammation 
First-line investigations 
Historically, once a clinical diagnosis of uveitis was made, a standard battery of first-line screening 
investigations was requested to start looking for a specific cause. These investigations included a full 
blood count (FBC) and erythrocyte sedimenatation rate (ESR), serum creatinine, syphilis serology, 
HIV testing, serum angiotensin converting enzyme levels (sACE) and a chest X-ray (CXR). If the 
investigations all returned negative results the cause of the uveitis would be listed as “idiopathic” 
and the patient would be treated empirically with corticosteroids and other immunosuppressive 
agents as needed. 
Today, however, if these tests are negative, a whole new array of investigations is being employed to 
enhance the search for an underlying cause. Many of these newer investigations are aimed at 
identifying infectious causes of uveitis. In some countries, these newer investigations have been in 
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routine clinical use for well over a decade but in South Africa these investigations have only recently 
become available and are not yet used routinely. 
The role of PCR and GWC 
In the 1990’s, publications started appearing that reported the use of PCR and local antibody 
analysis on ocular fluids (both aqueous and vitreous humor) to look for the presence of herpes 
viruses.77-79 One study found that PCR had a sensitivity of 95% for the diagnosis of untreated CMV 
retinitis in patients with AIDS 78 while another found that the sensitivity of local antibody analysis 
was much lower at 44%.79 Subsequent studies started using qualitative multiplex PCR which enabled 
the investigators to test for more than one herpes virus at the same time and eventually quantitative 
real-time PCR was employed to not only determine the presence of a specific virus but also to 
quantify the viral load.80,81 In a study from Thailand, real-time PCR was performed on ocular fluid 
samples from 100 HIV-negative patients and 47 HIV-positive patients with uveitis. Positive PCR 
results were found in 33% of HIV-negative patients and 70% of HIV-positive patients.56 Other authors 
found that calculation of the Goldmann-Witmer coefficient which reflects local antibody production 
provides additional information to that obtained by PCR alone.82,83 In their one study, GWC and PCR 
were both positive in 43% of cases while in 48% only GWC was positive and in 9% only PCR was 
positive. It was found that PCR detecting viral DNA tended to be positive early in infection while the 
GWC only became positive after a few weeks.82 In their other study, GWC was found to be more 
informative in immunocompetent patients while PCR was useful in immunocompromised patients.83 
By combining the results of PCR and GWC testing one therefore increases the likelihood of obtaining 
a positive result over a longer period of time in both immune-competent and immunocompromised 
patients. GWC determination has also been shown to have a higher sensitivity than PCR for the 
diagnosis of both ocular toxoplasmosis83 and rubella infection.65,66 A recent literature search 
revealed only three articles originating from South Africa regarding the use of anterior chamber (AC) 
taps and aqueous humor (AH) analysis to diagnose the cause of uveitis, one of which was our own 
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pilot study.14,84,85 This study is the first from South Africa to investigate the role of combined PCR and 
GWC testing for herpes viruses, rubella and toxoplasmosis in the diagnosis of infectious uveitis as 
the study by Schaftenaar et al used PCR and GWC to look for herpes viruses only. It is also one of the 
first studies worldwide to prospectively evaluate the role of PCR and GWC testing to diagnose 
infectious uveitis in HIV-positive and HIV-negative patients. 
The role of Epstein-Barr virus (EBV) as a cause of uveitis remains unclear. The first three cases of 
presumed EBV-associated uveitis were described in 199057 but EBV has only ever been 
demonstrated histologically in the retina on one occasion.86 More recent studies have reported 
finding high copy numbers of EBV DNA by quantitative PCR on ocular fluids although the significance 
of these findings remains uncertain.87,88 In our study, we aimed to explore this role of EBV further by 
measuring the EBV viral load on specimens that tested positive by multiplex PCR as well as 
performing an EBV GWC  to look for antibody production against the virus. If a high viral load is 
found in combination with significant antibody production it could indicate that EBV does act as a 
pathogen and is not merely present as an incidental commensal. 
Where does ocular syphilis fit in? 
Syphilis is caused by the spirochete Treponema pallidum and may cause ocular involvement during 
any of the four stages of disease namely primary, secondary, latent and tertiary syphilis.89,90 During 
the secondary and tertiary stages of the disease, uveitis is the most common ocular manifestation of 
syphilis.44 Embryologically, the optic nerve and retina are extensions of the brain and many authors 
contend that syphilitic retinitis and optic neuritis represent a form of neurosyphilis and should 
therefore be treated as such.89,91,92 Whether syphilitic anterior uveitis should be considered in the 
same light is the subject of an ongoing debate. Many experts suggest that all cases of syphilitic 
uveitis (SU) should be considered identical to neurosyphilis while others are not yet convinced.93 
When co-infection with HIV enters the picture, the diagnosis of SU and neurosyphilis becomes even 
more complicated. 
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The diagnosis of SU is made, after exclusion of other possible causes, if a patient has ocular 
inflammation compatible with syphilis and positive syphilis serology which should include both a 
non-treponemal test and a treponemal test. Non-treponemal tests include the Venereal Disease 
Research Laboratory (VDRL) and the rapid plasma reagin (RPR) which detect antibodies directed 
against membrane phospholipids such as cardiolipin. These tests are used to screen for active 
disease and to quantify antibodies but may give false positive results in diseases other than syphilis 
such as collagen vascular diseases.44 A treponemal test such as the fluorescent treponemal antibody 
absorption (FTA-ABS) test is used to confirm current or previous infection. Treponemal test 
reversion may occur in 5 – 17% of patients who were treated for early syphilis. This contradicts the 
common misconception that these tests always remain positive after infection by T pallidum – the 
so-called serological scar.44 
According to the Centres for Disease Control (CDC), confirmed neurosyphilis is diagnosed when VDRL 
testing is positive on cerebrospinal fluid (CSF) and probable neurosyphilis is diagnosed when CSF 
VDRL is negative but CSF protein and/or white cell count is elevated in the presence of clinical signs 
or symptoms which may include ocular findings.94 However, CSF abnormalities such as higher mean 
white cell counts and protein levels are common in HIV-infected patients, even in the absence of 
syphilis. Diagnosing probable neurosyphilis in HIV-infected patients is therefore problematic. 
The advent of techniques such as PCR has brought about interesting new diagnostic possibilities in 
both SU and neurosyphilis. PCR has been used to detect the presence of treponemal DNA in both 
aqueous and vitreous humor from eyes with suspected SU, thus confirming the diagnosis.91,95-97 It 
has also been used to detect treponemal DNA in CSF from patients with neurosyphilis.98 However, 
what still needed to be determined was whether performing PCR on both intraocular fluid and CSF 
from patients with suspected SU and neurosyphilis would enable us to develop a better 
understanding of how these two conditions relate to one another. 
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Western blotting is another technique that is able to confirm the diagnosis of syphilis by detecting 
antibodies to specific treponemal antigens. In a study that compared a Western blot to the FTA-ABS 
as a confirmatory test for syphilis both tests had sensitivities of 100% while the specificities were 
100% and 94.5% for the Western blot and FTA-ABS respectively.99 In another study, the Western blot 
had 93.8% sensitivity and 100% specificity compared to the 91.7% sensitivity and 92.0% specificity of 
the FTA-ABS.100 Western blotting has previously been used to detect antibodies against T pallidum 
antigens in the CSF of patients with neurosyphilis101 but there are no reports in the literature of it 
having been used for the detection of treponemal antibodies in aqueous or vitreous humor. The use 
of PCR to detect treponemal DNA and Western blotting to detect antibodies against T pallidum in 
the CSF and aqueous humor of patients suspected of having SU and neurosyphilis could potentially 
improve diagnostic accuracy and increase our insight into how these conditions relate to each other. 
Could it be TB? 
Intraocular TB (IOTB), also called TB-associated uveitis (TAU), is caused by Mycobacterium 
tuberculosis and represents a form of extrapulmonary tuberculosis (EPTB). In the United States, the 
proportion of EPTB has increased from 13.5 % in 1975 to 21.0% in 2006 and this phenomenon has 
been attributed to the rising prevalence of immune compromise.42 HIV co-infection plays an 
important role in this setting since EPTB may occur in up to 70% of patients who suffer from 
concomitant TB and HIV infection.42 Due to a combined lack of standardized diagnostic criteria as 
well as difficulty in making a laboratory diagnosis, the exact prevalence of IOTB is uncertain. In 
reports from India, a country where pulmonary TB (PTB) is endemic, uveitis was caused by TB in 
between 5.6 – 10.1% of cases.43 The majority of patients with IOTB have no history of PTB or TB in 
any other organ while about 60% of patients with EPTB do not have evidence of PTB.43 
IOTB has a multitude of clinical manifestations making diagnosis based on clinical findings alone 
extremely difficult. It is one of four intraocular inflammatory conditions that are collectively referred 
to as “the great mimickers in uveitis” and should therefore be considered in all patients with uveitis 
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– especially in areas where TB is endemic.3,43 Also, depending on the clinical manifestation, the 
inflammation may either be the result of direct tissue invasion by the organism or a hypersensitivity 
reaction to tubercular antigens.43,102  
By the time that this project started, diagnostic criteria had been proposed which allowed the 
clinician to make a diagnosis of either definitive ocular TB or presumed ocular TB.41 Definitive (or 
confirmed) ocular TB was diagnosed when M tuberculosis, or its DNA, could be demonstrated in 
ocular fluids by microscopy, culture or PCR. Presumed ocular TB, on the other hand, was diagnosed 
when a suggestive clinical picture was combined with indirect evidence of TB infection provided 
other uveitis entities have been excluded. Examples of this indirect evidence include a positive 
tuberculin skin test (TST), signs of active or healed pulmonary PTB on chest X-ray (CXR) or chest CT, a 
positive interferon gamma release assay (IGRA) or a response to empirical anti-tuberculosis therapy 
(ATT).3,41,42  
During the course of this project a revised classification was proposed by Gupta et al which now 
made provision for a diagnosis of confirmed, probable or possible IOTB.103 They identified six clinical 
signs commonly found in IOTB and in their classification one or more of these signs had to be 
present before a diagnosis of IOTB could be entertained. If one or more of the signs were present 
along with PCR, culture or microscopic evidence of TB on a sample taken from the eye then IOTB was 
confirmed. If one or more of the signs were present and there was evidence of TB elsewhere in the 
body and there was a positive TST or IGRA then probable IOTB could be diagnosed. Lastly, if one or 
more signs were present and there was either evidence of TB elsewhere in the body or there was a 
positive TST and/or IGRA then possible IOTB could be possible. The caveat in diagnosing probable or 
possible IOTB was that all other possible causes of IOTB needed to be excluded first before making a 
diagnosis of IOTB. We made use of this second classification during our study and present our 
published findings later. 
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Direct microscopy of a smear does not often aid the diagnosis of IOTB since intraocular fluids do not 
yield many acid-fast bacilli (AFB). For the same reason, attempts to culture M tuberculosis from 
ocular fluids often lead to false-negative results. Older culture media such as Lowenstein-Jensen also 
require a protracted incubation period of up to 8 weeks which cause a significant delay in diagnosis. 
Newer culture media, such as Middlebrook 7H9 broth used in the Mycobacteria Growth Indicator 
Tube (MGIT), are able to provide a positive result in a shorter period of time (median 14 days) but 
they also only need to be incubated for 5 weeks before a negative result can be recorded.104 The 
detectable limit of the MGIT test is stated as 10 organisms per ml which is usually adequate when 
analysing large volumes of fluid. However, the average AH sample size obtained during an AC tap 
varies between 0.1 – 0.2 ml which makes it easier to understand why the MGIT test has little chance 
of successfully culturing MTB from the eye. PCR to detect DNA from M tuberculosis in ocular fluids 
appears more useful. It can be performed on a very small amount of intraocular fluid since it 
amplifies the DNA in the specimen several times for easier detection. With early reported 
sensitivities between 37 – 47% and high specificity it has the potential to increase the number of 
confirmed diagnoses of IOTB.43 More recent reports have shown that the sensitivity of PCR testing 
for IOTB is on the increase. In 2013, Sharma et al described a multi-targeted PCR using 3 targets 
specific for MTB namely IS6110, MPB64 and protein b. They reported a sensitivity of 77.77% and 
specificity of 100% respectively.105 Later, the same researchers compared the sensitivity and 
specificity of devR PCR and MPB64 PCR for the diagnosis of IOTB. They found the sensitivity and 
specificity of devR PCR to be 64% and 100% respectively while that of MPB64 PCR was 72% and 
100% respectively.106 More recently, vitrectomy samples from 11 eyes were subjected to multi-
targeted PCR, GeneXpert MTB/RIF assays and a line probe assay (GenoType MTBDRplus) to detect 
the MTB genome in cases of multifocal serpiginoid choroiditis.107 The multi-targeted PCR was 
positive in 10 of 11 eyes while the line probe assay was positive in 6 of 11 eyes and the GeneXpert in 
4 of 11 eyes. At present, no studies have been published that evaluate the use of a combination of 
MGIT culture and TB-specific PCR to make a diagnosis of confirmed IOTB. 
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A TST or Mantoux test uses an intradermal injection of 5 units of purified protein derivative (PPD) 
which is then read 48-72 hours later. In parts of the world where TB is non-endemic, a positive TST 
can aid the diagnosis of IOTB.108-111  In the Western Cape, with its high prevalence of PTB, TST is not 
performed routinely in adults to screen for TB due to various reasons. These include the high 
prevalence of latent TB, the inability of the test to distinguish between active and latent TB and the 
fact that most adults in the region received Bacillus Calmette-Guérin (BCG) vaccinations during 
childhood. Interpretation of the test is said to be problematic in patients with HIV infection and 
false-positive results may be obtained in patients infected by non-TB mycobacteria (NTM). 
IGRAs are blood tests that measure in vitro release of interferon-gamma (IFN-γ) from peripheral 
blood cells in response to stimulation by specific antigens derived from M tuberculosis. The one test, 
called T-SPOT.TB (Oxford Immunotec, Oxford, UK), is an enzyme-linked immunospot (ELIspot) assay 
which quantifies IFN-γ secreting T-cells whereas the other, QuantiFERON®-TB Gold (QFT) test 
(Cellestis Inc., Chadstone, Victoria, Australia), is an enzyme-linked immunosorbent assay (ELISA) that 
measures IFN-γ concentration in supernatant.43 At the beginning of our study, the role of IGRAs in 
the diagnosis of IOTB was not yet completely understood. As is the case with TST, an IGRA cannot 
distinguish between active and latent infection.112 An IGRA result is, however, not influenced by 
prior BCG vaccination since the mycobacterial antigens used differ from those in BCG nor is it 
affected by NTM.110 Some studies, especially those from Singapore, have shown that TST was more 
sensitive in diagnosing IOTB than both T-SPOT.TB and QFT but that both the IGRAs were more 
specific in diagnosing IOTB.111,113,114 These studies also showed that the likelihood of having ITOB is 
significantly increased if both the TST and IGRA are positive.111,113 Another study has suggested that 
an IGRA should be considered instead of TST in immune-compromised patients as well as patients 
who had previously been vaccinated with BCG.112 In South Africa, the majority of patients with 
suspected IOTB would fall into one or both of these categories. A study from France showed that 
patients with presumed IOTB who had a higher QFT value where more likely to respond to ATT than 
those with lower values.115 In India, where TB is also highly prevalent, authors found the sensitivity 
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and specificity of QFT in detecting intraocular TB to be 82% and 76% respectively 116 while others 
reported favourable clinical outcomes in all QFT positive patients presumed to have IOTB who 
received ATT.117 Only one of these studies mentioned the HIV-status of the participants and, of note, 
none of the patients tested in that study had HIV infection. The role of IGRAs in diagnosing IOTB in 
an area with a high prevalence of both TB and HIV infections therefore still needed to be determined 
and we present our findings later in this dissertation. 
In most cases of TB, the lungs are the site of primary infection and imaging of the chest remains an 
important investigation in the workup of a patient with possible IOTB. A chest radiograph (CXR) is 
routinely requested as the first imaging modality since it is inexpensive and widely available. 
Unfortunately, the sensitivity of a CXR to detect PTB is relatively low and a normal CXR result does 
not exclude IOTB.41,110 Computed tomography (CT) scanning of the chest is a more sensitive imaging 
modality which is superior to CXR in diagnosing hilar lymphadenopathy and subtle parenchymal 
changes.110 Case series have been reported where both normal resolution chest CT and high 
resolution chest CT (HRCT) have enabled clinicians to diagnose IOTB in patients with normal 
CXRs.118,119 In instances where both the CXR and chest CT are negative but a strong suspicion of IOTB 
remains based on a positive IGRA result, combined positron emission tomography (PET) and CT 
scans have been performed.120,121 In one of these studies, evidence of metabolic activity in 
mediastinal or hilar lymph nodes was found in 9 of 20 (45%) patients with a positive QFT test while 
no abnormalities were only found in 4 of 20 (20%).120 Metabolic activity alone is however not 
enough to support a diagnosis of TB and microbiological evidence of TB was eventually only 
obtained in 2 cases. In the Western Cape, a prospective study to evaluate the role of HRCT in 
diagnosing IOTB is feasible and should be explored further. Despite the availability of PET/CT at our 
institution the high cost of this investigation initially precluded it from further investigation in our 
setting. However, during the course of this study a collaboration between die Divisions of 
Ophthalmology and Nuclear Medicine was initiated and the resulting findings about the role of 
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PET/CT in diagnosing the underlying cause of uveitis will be submitted for publication as a Master of 
Medicine dissertation by a registrar in the Division of Nuclear Medicine. 
Conclusion 
There are many unanswered questions when it comes to finding a specific underlying cause in a 
patient with uveitis anywhere in the world. Recent advances in diagnostic modalities have increased 
our chances of finding a cause but there have not been many significant reports from South Africa 
about the value of these modalities in a local context. HIV infection alters the susceptibility to 
infection throughout the human body and it is unlikely that the situation in the eye will be any 
different. Syphilis and TB commonly occur in HIV-infected patients but, as yet, it is not known 
whether these conditions cause uveitis more frequently in HIV positive patients than in HIV negative 
patients. Also, the relationship between ocular syphilis and neurosyphilis remains uncertain – 
especially against a background of HIV infection. Our study aimed to start providing answers to these 
important questions. 
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Chapter 2: Research question, aims and objectives 
Research question: 
Do the causes of intraocular inflammation differ between patients who are HIV-positive and HIV-
negative in the Western Cape Province, South Africa? 
Aim: 
To compare the causes of intraocular inflammation in HIV-positive patients and HIV-negative 
patients to determine whether significant differences exist 
Secondary aim: 
1. To determine whether ocular syphilis may occur in the absence of  neurosyphilis 
2. To evaluate the contribution of different special investigations in making the diagnosis of 
ocular tuberculosis in a endemic area 
Study design: 
Cross-sectional analytical study 
Objectives: 
In HIV-positive and HIV-negative patients in the Western Cape:                
1. To determine and compare the prevalence of non-infectious causes of intraocular 
inflammation  
2. To determine and compare the prevalence of viral causes (herpes viruses, rubella, HIV) of 
intraocular inflammation by analysis of aqueous humor and blood samples 
3. To determine and compare the prevalence of parasitic causes (toxoplasma) of intraocular 
inflammation by analysis of aqueous humor and blood samples  
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4. To determine and compare the prevalence of ocular syphilis and to study the relationship 
between ocular syphilis and neurosyphilis 
5. To determine and compare the prevalence of ocular tuberculosis and to ascertain the value 
of different special investigations in making this diagnosis 
6. To determine and compare the prevalence of idiopathic causes of intraocular inflammation 
 
Secondary objectives: 
1. To test aqueous humor and CSF samples of patients with positive syphilis serology to look 
for treponemal DNA and/or anti-treponemal antibodies 
2. To perform radiological, endoscopic, serological and microbiological investigations in 
patients with suspected ocular tuberculosis to determine which tests are most useful in our 
setting 
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Chapter 3: Original article – Published in Ocular Immunology and Inflammation 
Citation:  
Smit DP, Esterhuizen TM, Meyer D. The Prevalence of Intraocular Tuberculosis in HIV-positive and 
HIV-negative Patients in South Africa Using a Revised Classification System. Ocul Immunol Inflamm. 
2016;Dec 25:1-8. 
DOI: http://dx.doi.org/10.1080/09273948.2016.1263342 
Abstract 
Purpose: To report the prevalence of intraocular tuberculosis in South Africa using a revised 
classification system 
Methods: A prospective study to determine the underlying etiology in patients presenting with 
uveitis to a tertiary Eye Clinic.  
Results: Thirty-five of 106 patients (33.0%) were diagnosed with intraocular tuberculosis of which 11 
(31.4%) had HIV infection. Twenty-three patients (65.7%) had possible intraocular tuberculosis and 
12 (34.3%) probable intraocular tuberculosis. Patients with probable intraocular tuberculosis were 
younger than those with possible intraocular tuberculosis (p=0.003). More males (66.7%) had 
probable intraocular tuberculosis and more females (73.9%) had possible intraocular tuberculosis 
(p=0.031). More HIV positive patients had probable intraocular tuberculosis and more HIV negative 
patients had possible intraocular tuberculosis (p=0.002).  
Conclusions: South Africa has a high prevalence of intraocular tuberculosis. Younger, male, HIV 
positive patients more likely have probable intraocular tuberculosis while older, female, HIV 
negative patients more likely have possible intraocular tuberculosis. 
Keywords: intraocular tuberculosis; HIV; prevalence; South Africa; classification 
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Introduction 
Mycobacterium tuberculosis (MTB) infection in humans is common worldwide but nowhere more so 
than in Africa. In 2014, 9.6 million people were estimated to have fallen ill with TB worldwide and 
Africa accounted for 28% of these cases. The incidence on the African continent is 281 cases per 
100 000 people as compared to the global average of 133 cases per 100 000 people.1 
 Of the 9.6 million people who contracted TB worldwide in 2014, an estimated 1.2 million (12%) 
were HIV positive and Africa accounted for 74% of cases. In 2014 the prevalence of TB in South 
Africa was 696 cases per 100 000 population and the incidence  834 cases per 100 000 – almost 
three times more than on the rest of the continent and by far the highest of the 22 high-burden 
countries highlighted in the WHO annual report. In South African TB patients, 61% were reported to 
have HIV co-infection which is five times higher than the global figure. 1  In patients with active TB 
there is wide variation in the reported prevalence of intraocular TB (IOTB).  IOTB occurs more 
commonly in patients with extrapulmonary TB (>20%) than in those with pulmonary infection 
(±1%).2  Furthermore, the reported rates of IOTB also vary by region with less than 1% occurring in 
North America compared to more than 10% in highly endemic areas.3-5 
  
The difficulty of confidently diagnosing IOTB due to the absence of gold standard tests is well 
documented and this has led to the proposal of classification systems that make provision for 
different levels of certainty with which IOTB can be diagnosed.6  In 2007, Gupta et al proposed a 
classification which enabled clinicians to diagnose either “confirmed IOTB” or “presumed IOTB” 
based on the amount of supporting evidence available to them.4  More recently, in 2014, an updated 
classification was proposed which now provides criteria to diagnose IOTB as either “confirmed”, 
“probable” or “possible”.7  The rationale for adding the “possible IOTB” category was to enable 
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clinically ambiguous cases to also be diagnosed as IOTB which was not possible when using the 
earlier classification. 
 A recent study by Schaftenaar et al reported that TB was found to be the cause of uveitis in 18 of 
103 cases (17.5%) in the Limpopo Province of South Africa.8 These findings were based on Xpert 
MTB/RIF assays in patients with productive cough and chest X-rays taken in patients with suspected 
TB.  In this report we shall describe our findings regarding the prevalence of IOTB in uveitis patients 
with and without HIV infection in South Africa using the most recently proposed classification 
mentioned above. 
Materials and methods 
Study participants and overview of management 
 A prospective study was conducted where 106 consecutive patients presenting with either a new 
diagnosis of uveitis or chronic uveitis of unknown cause were enrolled between February 2014 and 
July 2015.  They presented to the Eye Clinic at Tygerberg Academic Hospital, a tertiary referral 
hospital in the northern suburbs of Cape Town, South Africa. Ethics approval was obtained from the 
Health Research Ethics Committee of Stellenbosch University (Ref no N13/10/146). Participants were 
excluded if they: 1) were under 18 years of age, 2) had uveitis with known or clinically obvious cause 
and 3) were not willing to consent to HIV testing after appropriate counselling. After enrolment 
patients completed a detailed systemic review questionnaire followed by a full ocular examination 
and a standardised panel of investigations as set out below. 
Investigations 
All of the participants underwent blood tests to determine their HIV status, full blood count, 
erythrocyte sedimentation rate, creatinine, venereal diseases research laboratory test and 
Treponema pallidum antibodies for syphilis as well as serum angiotensin converting enzyme levels. 
Chest X-rays and dipstick urinalysis were also requested in all cases. A tuberculin skin test (TST) could 
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only be done in 89 participants as there was an international shortage of purified protein derivative 
(PPD) during a part of the study. The participants received a 0.1ml intradermal injection of 5 units of 
PPD-S 5TU to the volar aspect of the forearm and the reaction was measured with a ruler 48 – 72 
hours later. The TST was considered positive if it was >10 mm in HIV negative participants and >5 
mm in HIV positive participants.4 
 A QuantiFERON®-TB Gold (QFT) test (Cellestis Inc., Chadstone, Victoria, Australia) was performed 
according to the manufacturer’s instructions in 105 participants with blood being taken before 
intradermal injection of PPD for the TST in all cases. The QFT result was considered positive if the TB 
Antigen minus Nil value was ≥ 0.35 IU/mL and >25% of the Nil value. An HLA-B27 test was only 
requested in cases with severe fibrinous anterior uveitis and Anti-Streptolysin O titers were only 
requested in participants under 40 years of age. Anterior chamber taps were subsequently 
performed in cases where baseline testing was normal and aqueous humor (AH) samples were 
tested for toxoplasma, herpes viruses and rubella. A multiplex polymerase chain reaction (PCR) test 
was used to test AH samples for herpes viruses 1 to 6 as previously described.9  Goldmann-Witmer 
Coefficient determinations were performed on AH and serum for toxoplasma, herpes simplex virus, 
varicella-zoster virus and cytomegalovirus at the University Medical Centre Utrecht, Netherlands.10,11 
In cases where a high index of suspicion for IOTB existed after all other potential causes had already 
been excluded AH samples were also collected for Mycobacteria Growth Indicator Tube (MGIT) 
culture and IS6110-targeted TB PCR testing.12 
Statistical analysis 
IBM SPSS version 23 was used to analyse the data. A p value <0.05 was considered as statistically 
significant. Data were summarised using mean, standard deviation and range in the case of 
quantitative normally distributed variables, and median and interquartile range for ordinal or 
skewed variables. Nominal and binary data were represented in frequency tables. Associations 
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between categorical variables were represented in contingency tables with Pearson’s chi square or 
Fisher’s exact tests as appropriate. Means were compared between groups using t-tests or ANOVA 
as appropriate and medians were compared using Mann Whitney or Kruskal-Wallis tests according 
to the number of groups being compared.  
Results 
Demographics and clinical findings 
A total of 106 consecutive participants with uveitis were enrolled during the course of our study. 
After consideration of the clinical findings and the results of the special investigations, 71 
participants (67.0%) were either diagnosed with an underlying etiology other than TB or no specific 
cause was found. Figure 1 illustrates that in the remaining 35 participants (33.0%), 23 fulfilled the 
criteria to be classified as possible IOTB (65.7%) while 12 were classified as probable IOTB (34.3%). 
The criteria used to diagnose possible or probable IOTB in each of these cases are tabulated in Table 
1.  
No cases of confirmed IOTB were recorded since all TB cultures and TB PCR tests were negative. The 
mean age of patients diagnosed with possible IOTB was 42.7 ± 14.3 years while the mean age of 
patients diagnosed with probable IOTB was 31.1 ± 7.2 years (Table 2). Patients diagnosed with 
probable IOTB were therefore younger than those diagnosed with possible IOTB (P=0.003). A total of 
21 females (60.0%) and 14 males (40.0%) were diagnosed with IOTB. More males (66.7%) than 
females (33.3%) were diagnosed with probable IOTB while more females (73.9%) than males (26.1%) 
were diagnosed with possible IOTB (P=0.031). These differences could however not be ascribed to 
differences in HIV status between the two genders. Seventeen cases (48.6%) had bilateral and 18 
cases (51.4%) unilateral involvement. No association existed between laterality and a diagnosis of 
possible or probable IOTB (P=0.11). Anatomically, 19 cases had anterior uveitis (54.3%), 15 
panuveitis (42.9%) and 1 posterior uveitis (2.9%). Of the 19 cases with anterior uveitis, 13 were HIV- 
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and 6 were HIV+ while of the 15 cases with panuveitis 10 were HIV- and 5 were HIV+. No significant 
relationship between anatomical involvement of uveitis and HIV status could be demonstrated 
(P=0.48). A diagnosis of possible IOTB was made in 15 of the 19 anterior uveitis cases while in the 
other 4 cases a diagnosis of probable IOTB was made. In 8 of the 15 panuveitis cases possible IOTB 
was diagnosed while probable IOTB was diagnosed in 7 cases. Anatomical distribution of uveitis was 
not related to a diagnosis of possible or probable IOTB in this study (P=0.11). Clinical features 
suggestive of a granulomatous uveitis were present in 22 cases (62.9%) and absent in 13 cases 
(37.1%). In patients with granulomatous uveitis, 12 cases (54.5%) had anterior uveitis, 9 cases 
(40.9%) had panuveitis and 1 case (4.5%) had posterior uveitis. 
HIV status 
IOTB was diagnosed in 35 cases of which 11 were HIV+ (31.4%) and 24 were HIV- (68.6%). In the 
HIV+ patients the median CD4+ cell count was 249 x 106/L (range 809 x 106/L). Of the 11 HIV+ cases, 
8 had probable IOTB and 3 had possible IOTB while of the 24 HIV- cases 4 had probable IOTB and 20 
possible IOTB (Figure 1). HIV+ patients were therefore more likely to have a diagnosis of probable 
IOTB than possible IOTB (RR=4.36; 95% CI 1.66 - 11.45) (P=0.002). Conversely, HIV- patients had a 
higher chance of being diagnosed with possible IOTB than probable IOTB (RR=3.06; 95% CI 1.15 -
8.15) (P=0.002). As stated previously, participants with possible IOTB were older than participants 
with probable IOTB but this did not take HIV status into account. In HIV- cases, participants with 
probable IOTB were younger (Mean age 28.0 ± 9.5 years) than those with possible IOTB (Mean age 
43.0 ± 14.4 years) while in HIV+ cases participants with probable IOTB were also younger (Mean age 
32.6 ± 5.8 years) than those with possible IOTB (40.7 ± 16.3 years) thus demonstrating a trend for 
participants with possible IOTB to be older than participants with probable IOTB regardless of HIV 
status (P=0.06). In 3 cases (numbers 2, 4 and 7) a diagnosis of probable IOTB was made despite the 
participants not having immunological evidence of TB infection. In all 3 cases the QFT test was 
negative, two had a negative TST and one did not have a TST result available. However, in all 3 cases 
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there was other evidence of extraocular TB as tabulated and all 3 cases had advanced HIV infection 
with mean CD4+ count of 68 x 106/L (range 9 x 106/L). In the group of 22 participants who had 
granulomatous uveitis 8 were HIV+ (36.4%) and 14 were HIV- (63.6%). The median CD4+ count in the 
HIV+ group with granulomatous uveitis was 220 x 106/L compared to 249 x 106/L in the HIV+ group 
with non-granulomatous uveitis (p=0.63). In the HIV+ group the median CD4+ count of participants 
with anterior uveitis was 464 x 106/L compared to 72 x 106/L in participants with panuveitis 
(p=0.068). 
Discussion 
The prevalence of IOTB has not been previously reported from South Africa which is the country 
with the highest prevalence and incidence of TB in the world.1  In our study based in a tertiary 
referral hospital in the northern suburbs of Cape Town, 35 out of 106 participants (33.0%) had 
clinical and other findings meeting the revised criteria proposed by Gupta et al7  for a diagnosis of 
either possible or probable IOTB after other possible causes had been rigorously excluded. At first 
glance, this prevalence of 33.0% appears high when compared to published numbers from other 
parts of the world. In the United States the prevalence has been reported as 1%, in China and Italy 
4% and 6% respectively while in Saudi Arabia 16%.3  Figures originating from India range from as low 
as 0.39 – 1.39%13  to as high as 20.8%.14 ,15  If one however compares the overall prevalence of TB in 
China (89 cases per 100 000) and in India (195 cases per 100 000) to that of South Africa (696 cases 
per 100 000) it becomes clear that TB in South Africa is 7 times more prevalent than in China and at 
least 3 times more prevalent than in India.1 The same WHO report also shows that South Africa has 
61% HIV+ TB patients compared to the 2% in China and 4% in India. It can therefore be expected that 
the prevalence of IOTB in South Africa should be higher than in other countries. 
In this study we found that in all patients diagnosed with IOTB, those with probable IOTB were 
significantly younger than those with possible IOTB. This trend, whilst not reaching statistical 
significance, also persisted when the patients with IOTB were divided into HIV+ and HIV- subgroups 
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which seems to indicate that this phenomenon was not necessarily linked to a patient’s HIV status. 
In order to diagnose probable IOTB when using the revised classification, the clinician needs some 
radiological or microbiological evidence of TB infection elsewhere in the patient’s body while to 
diagnose possible IOTB such evidence is not required. It therefore appears that in our study cohort 
younger patients were more likely to have evidence of active infection while older patients only had 
evidence of prior exposure to TB which most likely reflects their prolonged exposure to MTB in a 
highly endemic environment. The strong male preponderance of probable IOTB and the strong 
female preponderance of possible IOTB is more difficult to unravel. A difference in HIV status 
between the two genders was considered as a possible explanation but statistical analysis could not 
validate this theory. 
This study demonstrated that HIV+ patients were more likely to have a diagnosis of probable IOTB 
while HIV- patients were more likely to have a diagnosis of possible IOTB. It stands to reason that 
HIV+ patients with a compromised immune system would be more susceptible to active TB infection 
while the converse should apply to HIV- patients. The 3 HIV+ cases who were diagnosed with 
probable IOTB despite not having immunological evidence of TB infection illustrate this point. All 3 
cases suffered from severe immunosuppression with CD4+ counts between 63 x 106/L and 72 x 106/L 
which most likely explains why they were unable to mount a positive immunological response in the 
first instance. They all did however have evidence of extraocular TB including a pleural effusion, 
positive sputum culture and chest CT suggestive of pulmonary TB. In our opinion this highlights the 
fact that in HIV+ patients with low CD4+ counts (<100 x 106/L) one cannot rely too heavily on 
immunological evidence of TB infection as a diagnostic criterion as these tests will often produce 
false negative results. 
A clinical picture suggestive of granulomatous uveitis was more common in HIV- participants. 
However, in the HIV+ group the median CD4 count was lower in participants with granulomatous 
uveitis which shows that a granulomatous picture does not require a high CD4+ count. In fact, 
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granulomatous uveitis was seen in participants with CD4+ counts as low as 54 x 106/L. In the HIV+ 
group the median CD4+ count of participants with anterior uveitis (464 x 106/L) was higher than 
those with panuveitis (72 x 106/L) and, although we could only demonstrate a trend due to the small 
numbers involved, this might support the theory that panuveitis results from direct mycobacterial 
invasion while anterior uveitis is more likely an immune response against circulating antigens.3 
The revised classification we used in this study enabled us to assign a diagnosis of IOTB to patients 
who we previously would have had to label as idiopathic using earlier classifications. However, 
despite the improvements incorporated into this classification, we still encountered cases during the 
course of the study where we could not diagnose patients as having IOTB despite having a high index 
of clinical suspicion as they did not meet all of the required criteria. We acknowledge that the 
protean manifestations of ocular TB make it virtually impossible to include an exhaustive list of 
clinical signs in the classification that could be indicative of TB.16 
For this reason, and based on our experience, we are of the opinion that a positive response to a 
trial of anti-TB treatment (ATT) remains valuable in cases where ocular TB is suspected but 
diagnostic criteria cannot be met. . In immunocompetent patients with a positive QFT and/or TST 
and compatible clinical signs that aren't contained in the current criteria a positive trial of therapy 
could support a diagnosis of possible IOTB. In the setting of advanced HIV infection this becomes 
even more important as we have demonstrated that these patients often have false negative 
immunological tests.   
A potential limitation of our study is that we were only able to perform PCR testing targeting IS6110 
at the time the study was conducted. Since then it has been reported that multi-targeted PCR is 
more sensitive in the diagnosis of IOTB. In one study where IS6110, MPB64 and protein b were 
targeted the sensitivity and specificity were 77% and 100% respectively.17 Another study showed 
that devR PCR alone was not as sensitive as MPB64 PCR alone but a combination of the two targets 
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increased the sensitivity to 80%.18 Future studies in our highly endemic setting should therefore 
consider using multi-targeted PCR to help diagnose IOTB. 
In a recent development from India, new guidelines for the management of extrapulmonary TB have 
been introduced (INDEX-TB Guidelines: http://icmr.nic.in/guidelines/TB/Index-
TB%20Guidelines%20-%20green%20colour%202594164.pdf). These guidelines contain an updated 
classification of IOTB which now consists of three new diagnostic categories namely possible, 
clinically diagnosed and bacteriologically confirmed ocular TB. It also lists molecular evidence of MTB 
infection as one of the diagnostic criteria for possible ocular TB which could prove useful in HIV+ 
patients with a low CD4+ count who are prone to false negative TST and/or IGRA results. Further 
research is required to determine how useful this new classification will be in a clinical setting. 
Conclusion 
South Africa has the highest incidence and prevalence of TB in the world and the prevalence of IOTB 
calculated in this study is also higher than those reported from other countries. The revised 
classification proposed for the diagnosis of IOTB succeeded in making it possible to diagnose 
clinically ambiguous cases as IOTB which would not have been possible if the earlier classification 
system was used.  The newly introduced INDEX-TB guidelines provide an updated classification of 
IOTB which could be used in future research especially in settings with a high prevalence of both TB 
and HIV.  
Figure 1 Diagnoses and HIV status 
 
 
 
                                                                                
Table 1: The criteria used to diagnose possible or probable IOTB in our cases. 
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Table 1 continued 
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Table 2: Demographics and anatomical classification of study cohort 
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Characteristics All IOTB (n=35) Possible IOTB (n=23) Probable IOTB (n=12) p-value 
     Age, years (±SD) 38.7 (13.4) 42.7 (14.3) 31.1 (7.2) 0.003 
HIV+ 
 
40.7 (16.3)  32.6 (5.8)  
 HIV- 
 
43.0 (14.4)  28.0 (9.5)  0.06 
     Gender (%) 
    Male 14 (40.0) 6 (26.1) 8 (66.7) 
 Female 21 (60.0) 17 (73.9%) 4 (33.3) 0.031 
     Anatomical distributiona (%) 
   Anterior 19 (54.3) 15 (65.2) 4 (33.3) 
 Intermediate 0 (0) 0 (0) 0 (0) 
 Posterior 1 (2.9) 0(0) 1 (8.3) 
 Panuveitis 15 (42.9) 8 (34.8) 7 (58.3) 0.11 
      Laterality (%) 
    Right eye 6 (17.1) 6 (26.1) 0 (0) 
 Left eye 12 (34.3) 6 (26.1) 6 (50.0) 
 Both eyes 17 (48.6) 11 (47.8) 6 (50.0) 0.11 
     HIV (%) 
    Positive 11 (31.4) 3 (13.0) 8 (66.7) 
 Negative 24 (68.6) 20 (87.0) 4 (33.3) 0.002 
     a Standardized Uveitis Nomenclature (SUN) Working Group criteria 
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Classification of Intraocular Tuberculosis: A South African Perspective 
Dear Editor 
We read the paper about the new classification of intraocular tuberculosis (IOTB) proposed by Gupta 
et al1 with great interest as we work in the Eye clinic of a tertiary hospital in suburban Cape Town, 
South Africa. According to the 2015 WHO Global tuberculosis report, South Africa has both the 
highest incidence (834 cases per 100 000) and prevalence (696 cases per 100 000) of TB of any 
country worldwide.2 We used the new classification in a prospective study that included 106 
consecutive patients, with and without HIV infection, presenting to our clinic with uveitis over a 
period of 17 months and found that 35/106 (33.0%) patients could be classified as having either 
possible or probable IOTB. (unpublished data) 
The new classification enabled us to diagnose IOTB in clinically ambiguous cases where such a 
diagnosis would not have been possible using earlier classifications.3 We did however discover that 
we would have been able to diagnose more cases of IOTB if the new classification included a few 
minor modifications.  We present two cases, one HIV negative and the other HIV positive, to support 
this view. 
Case 1 
A 34-year-old lady presented with a 4 year history of left ocular discomfort and redness. She was 
referred to us by an endocrinologist to whom she had presented with a Cushingoid appearance 
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secondary to prolonged oral corticosteroid use. She had previously consulted several other 
ophthalmologists but a definitive cause for her eye problem had not been found. On examination 
she had an uncorrected visual acuity (VA) of 0.7-1 in the affected eye which corrected to 1.0 with a 
pinhole. Both the episcleral and scleral blood vessels were diffusely injected and the sclera had a 
bluish tinge superiorly (Figure a). Her cornea showed areas of stromal scarring with deep stromal 
blood vessels at the 3 o’clock position.  Corneal sensation was intact. A trace of flare and cells was 
present in the anterior chamber and the rest of the examination was normal. A clinical diagnosis of 
sclerokeratouveitis was made and investigations were requested to search for an underlying cause. 
HIV testing, syphilis serology and HLAB27 were negative. The full blood count (FBC), erythrocyte 
sedimentation rate (ESR), serum angiotensin converting enzyme (sACE), dipstick urinalysis, chest X-
ray (CXR) and high resolution chest CT (HRCCT) were all normal. Aqueous humour PCR testing for 
herpesviruses 1 – 6 was negative. Both her Quantiferon (QFT) interferon gamma release assay (7.25 
IU/mL) and tuberculin skin test (TST = 20mm) showed strong positive results. Given the absence of 
other positive findings as well as the chronicity and side effects of corticosteroid treatment it was 
decided to start a trial of ATT with rifampicin, isoniazid, pyrazinamide and ethambutol. Three weeks 
later a significant improvement was noted in her left eye and she reported that she had 
discontinued all other medication one week after commencing ATT due to the dramatic positive 
response to treatment (Figure b). 
Case 2 
A 30-year-old lady, on antiretroviral (ARV) treatment for 9 years, presented with a 3 week history of 
reduced vision, pain and redness in her left eye. Her right eye was unaffected. She had been treated 
for pulmonary TB twice before in 2001 and 2005. The VA in her left eye was light perception with 
poor projection in all four quadrants. She was found to have scanty keratic precipitates and 2+ cells 
with some fibrin in the anterior chamber. The vitreous humor also contained 2+ cells and fundus 
examination revealed multiple subretinal masses with elevation of the sensory retina (Figure c). A 
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left-sided panuveitis was diagnosed clinically and investigations were requested to look for an 
underlying cause. Despite ARV treatment her CD4+ count was 69 x 106/L. The FBC and sACE were 
normal, syphilis serology was negative but ESR was raised at 104 mm/hr. Both QFT (0.01 IU/mL) and 
TST (0 mm) were negative and CXR was normal. HRCCT showed a 16 x 15 x 23mm mass in the right 
lower lobe as well as small nodules with “tree in bud” configuration in the right middle lobe but 
sputum microscopy, TB culture and GeneXpert testing were negative. Broncho-alveolar lavage (BAL) 
was considered but given her previous history of PTB, her low CD4+ count, her chest CT findings and 
the high clinical index of suspicion for IOTB a trial of four-drug ATT (as above) was prescribed after 
consultation with our Infectious Diseases specialists, despite the fact that she did not meet the 
criteria for a diagnosis of IOTB according to the new classification. A repeat HRCCT 3 months after 
initiation of treatment showed complete resolution of the lung pathology and 4 months after 
commencing ATT her left eye no longer showed any signs of inflammation (Figure d). 
These case reports illustrate that the proposed classification as it currently stands will under certain 
circumstances not lead to a diagnosis of IOTB even if it is strongly suspected clinically and there are 
various reasons for this. Firstly, the classification does not include the full spectrum of clinical signs 
compatible with a diagnosis of ocular TB as this would presumably make it too cumbersome.4 
Although the emphasis here is on intraocular TB it is well known that TB may cause scleritis with or 
without associated corneal or intraocular involvement and therefore including scleritis in the 
classification as one of the suggestive clinical signs would allow it to identify more cases of ocular TB. 
Secondly, the classification does not make provision for unusual presentations of IOTB in 
immunocompromised patients. Babu et al5 found that in HIV/AIDS cases choroidal granulomas were 
still the most common manifestation of IOTB but that subretinal masses and panophthalmitis could 
also occur. Thirdly, the classification does not address the effect of severe immunosuppression on 
QFT and TST results which often become false negative when CD4+ counts drop below 100 x 106/L. 
We would therefore suggest that immunological evidence of TB infection not be considered 
essential to diagnose IOTB in severely immunocompromised patients provided the rest of the 
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criteria are met. Lastly, in contrast to the earlier classification,3 the new classification does not 
contain a positive trial of ATT as a diagnostic criterion. As illustrated in both cases, a positive 
therapeutic trial can be very valuable in cases where the clinical presentation does not include the 
clinical signs considered suggestive of IOTB and/or immunological evidence of TB infection cannot be 
obtained in severely immunocompromised individuals.  
In our experience, the most recently proposed classification of IOTB by Gupta et al has succeeded in 
its goal of increasing the number of cases of intraocular inflammation that can correctly be 
attributed to TB and has proven valuable in our clinical practice. However, in our highly endemic 
setting we have found that by including a few more suggestive clinical signs, making certain 
exceptions in severely immunocompromised cases and reintroducing a positive trial of ATT as a 
diagnostic criterion we could potentially further improve the accuracy with which this classification 
identifies cases of IOTB. 
Derrick Smit FCOphth(SA) 
David Meyer FCOphth(SA), PhD 
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Figure 1 caption 
Figure 1 (a) Chronic left sclerokeratouveitis on presentation, (b) left eye 3 weeks after starting four 
drug anti-TB treatment, (c) subretinal masses and elevation of the sensory retina of the left eye on 
presentation and (d) no residual activity 4 months after starting anti-TB treatment 
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Abstract 
Purpose: To compare QuantiFERON®-TB Gold and tuberculin skin testing as diagnostic tests for 
intraocular tuberculosis in HIV positive and negative patients. 
Methods: A prospective study evaluating two different tests to help diagnose intraocular 
tuberculosis 
Results: Thirty-five of 106 patients (33.0%) were diagnosed with intraocular tuberculosis including 
11 (31.4%) with HIV infection. Patients were 6.95 times more likely to have intraocular tuberculosis if 
TST alone was positive (p<0.001) versus 2.19 times more likely if Quantiferon alone was positive 
(p=0.04). Tuberculin skin testing showed superior specificity (60.3% vs 33.3%)(p=0.001) but similar 
sensitivity (90.3% vs 85.7%), positive (54.9% vs 40.5%) and negative predictive values (92.1% vs 
81.5%) compared to Quantiferon. Specificity did not increase significantly if both skin testing and 
Quantiferon were positive.  
Conclusions: In South Africa with its high HIV burden and limited public health resources 
Quantiferon testing should not replace tuberculin skin testing as it provides little additional 
diagnostic information. 
Keywords: intraocular tuberculosis; diagnosis; HIV; Quantiferon; tuberculin skin test; South Africa 
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Introduction  
Mycobacterium tuberculosis (MTB) infection in humans is a worldwide occurrence but the burden of 
disease is much higher in certain areas. In 2014, 9.6 million people contracted TB worldwide and 1.2 
million (12%) of these were HIV positive with 74% of those cases coming from Africa.1 
In South Africa the prevalence of TB in 2014 was 696 cases per 100 000 population and the incidence 
834 cases per 100 000 – higher than any other country mentioned in the WHO annual report.1 
Furthermore, 61% of South African TB patients had HIV co-infection which is five times higher than 
the global average.  
For many years the tuberculin skin test (TST) formed the cornerstone of immunological testing for 
MTB infection and, more recently, the interferon-gamma release assays (IGRAs) were developed to 
attempt to improve the accuracy with which different forms of MTB infection could be diagnosed. 
Many authors have reported and commented on the clinical value of both TST and IGRAs in the 
diagnosis of intraocular tuberculosis (IOTB).2-11 It has been reported that false-negative TST results 
can exceed 50% in patients with decreased cellular immunity including those with HIV infection.12 It 
has also been suggested that IGRAs may be more specific than TST in patients with prior BCG 
vaccination13 and more sensitive than TST in HIV-infected patients.12 In this study we compared an 
IGRA (QuantiFERON®-TB Gold) with TST as a diagnostic test for IOTB in HIV positive and HIV negative 
patients in Cape Town, South Africa. 
Materials and methods 
Study participants and management 
We conducted a prospective study including consecutive patients with either a new diagnosis of 
uveitis or chronic uveitis of unknown cause. Between February 2014 and July 2015 a total of 106 
patients presenting to the Eye Clinic at a tertiary referral hospital in the northern suburbs of Cape 
Town, South Africa were enrolled after obtaining informed consent. The study was approved by the 
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Health Research Ethics Committee of Stellenbosch University (Ref no N13/10/146). Patients were 
not included if they: 1) were under 18 years of age, 2) had uveitis with known or clinically obvious 
cause and 3) would not consent to HIV testing after appropriate counselling. A detailed systemic 
questionnaire was answered verbally by all patients. This was followed by a comprehensive ocular 
examination as well as a standardised panel of special investigations. 
Investigations 
All participants underwent an extensive battery of special investigations to exclude possible causes 
of uveitis other than TB (Table 1).14  
Classification of IOTB 
In our study we used the revised classification system for IOTB proposed by Gupta et al.15 According 
to this classification patients with IOTB may fall into one of three clinical diagnostic groups namely 
confirmed, probable and possible IOTB based on the presence of clinical signs suggestive of IOTB and 
the amount of microbiological, radiological and immunological evidence available to the clinician. 
Statistical analysis 
IBM SPSS version 23 was used to analyse the data. A p value <0.05 was considered as statistically 
significant. Continuous data were compared between two groups using t tests or Mann Whitney 
tests as appropriate. Categorical data were compared using chi square tests, and relative risks and 
95% confidence intervals were reported as effect measures. Measures of diagnostic accuracy 
including AUC and likelihood ratios were computed using the “diagti” command in Stata version 14. 
McNemar’s chi square tests for paired proportions were used to compare sensitivity and specificity 
between the two tests.  
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Results 
Demographics and clinical findings 
A total of 106 consecutive patients with uveitis were enrolled during the study period of which 66 
(62.3%) were HIV- and 40 (37.7%) HIV+. Seventy-one cases (67.0%) either had an underlying etiology 
other than TB or were considered idiopathic. The remaining 35 participants (33.0%) were diagnosed 
with IOTB where 23 patients (65.7%) had possible IOTB and the remaining 12 probable IOTB (34.3%). 
No patients were diagnosed with confirmed IOTB as all TB cultures and PCRs were negative. 
The clinical characteristics of the participants are shown in Table 2. The mean age of patients with 
IOTB was 38.7 ± 13.4 years and most of the patients were female (n=21, 60.0%). Both eyes were 
involved in 17 cases (48.6%) and 18 cases (51.4%) were unilateral. Nineteen cases (54.3%) had 
anterior uveitis, 15 cases (42.9%) panuveitis and 1 case (2.8%) posterior uveitis. HIV testing was 
positive in 11 cases (31.4%) and negative in 24 cases (68.6%). HIV+ cases had a median CD4+ cell 
count of 249 x 106/L (range 809 x 106/L).  
QFT and TST results in the total study cohort 
QFT tests were performed in 105 of 106 cases of which 4 (3.8%) had indeterminate results. Of the 
remaining 101 QFT results, 74 (73.3%) were positive and 27 (26.7%) negative (Figure 1). Fifty-two 
cases (70.3%) with a positive QFT result were HIV- and the remaining 22 cases (29.7%) HIV+. In the 
group with negative QFT results, 13 cases (48.2%) were HIV- and 14 cases (51.8%) HIV+. HIV- cases 
were therefore more likely than HIV+ cases to have a positive QFT result (p=0.04). TST results were 
obtained in 89 cases of which 38 (42.7%) were negative and 51 (57.3%) positive (Figure 1). In the 
group with positive TST results, 37 cases (72.5%) were HIV- and 14 cases (27.5%) HIV+ while in the 
group with negative results, 21 cases (55.3%) were HIV- and 17 cases (44.7%) HIV+. This 
demonstrated a trend for HIV+ cases to have negative TST results (p=0.09). In the HIV+ group (n=40, 
37.7%), the median CD4+ count of cases with negative QFT results was noticeably lower at 93 x 106/L 
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[interquartile range 69 to 184] compared to the 415 x 106/L [interquartile range 234 to 610] of cases 
with positive QFT results (P = 0.005)(Figure 2). Also in the HIV+ group, the median CD4+ count of 
cases with negative TST results was again noticeably lower at 156 x 106/L [interquartile range 75 to 
414] as opposed to 443 x 106/L [interquartile range 121 to 716] in cases with positive TST results 
(p=0.04)(Figure 3). In the HIV- group, 33 of 66 cases (50.0%) had positive results for both QFT and 
TST while in the HIV+ group only 12 of 40 cases (30.0%) had positive results for both tests. Both tests 
were therefore more likely to have positive results in HIV- cases (p=0.043). In the HIV- group, 10 of 
66 cases (15.2%) tested negative for both QFT and TST while in the HIV+ group 16 of 40 cases 
(40.0%) had negative results for both tests. Patients were therefore 2.05 times more likely to have 
negative results for both tests if they were HIV+ (RR=2.05; 95% CI 1.31 – 3.22) (P=0.004). 
Discussion 
In our study, a diagnosis of IOTB (possible or probable) was made in 35 of 106 cases (33.0%). When 
analysing each test individually, the TST alone (71.0%; 95% CI 0.60 – 0.80) had a higher diagnostic 
accuracy than the QFT test alone (51.0%; 95% CI 0.41 – 0.61) (Table 3). Patients were 6.95 times 
more likely to have a diagnosis of possible or probable IOTB if the TST test alone was positive than if 
it was negative (RR=6.95; 95% CI 2.28 – 21.19) (p<0.001) but were only 2.19 times more likely to 
have a diagnosis of possible or probable IOTB if the QFT test alone was positive than if it was 
negative (RR=2.19; 95% CI 0.95 – 5.06) (p=0.04). Compared to a positive QFT alone, a positive TST 
alone had a similar sensitivity (90.3%; 95% CI 0.73 – 0.97 vs 85.7%; 95% CI 0.69 – 0.95; p=1.000), 
significantly higher specificity (60.3%; 95% CI 0.47 – 0.73 vs 33.3%; 95% CI 0.23 – 0.46; p=0.001), and 
similar positive and negative predictive values (PPV) (54.9%; 95% CI 0.40 – 0.69 vs 40.5%; 0.29 – 
0.53), (NPV) (92.1%; 95% CI 0.78 – 0.98 vs 81.5%; 0.61 – 0.93).  Area under the receiver operator 
characteristic curve (AUC) was borderline non significantly different between the two tests (0.75; 
95% CI 0.67 – 0.84 vs 0.60; 95% CI 0.51 – 0.68).  
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If either the QFT or TST was positive,  patients were 3.47 times more likely to have a diagnosis of 
possible or probable IOTB than if both were negative (RR=3.47; 95% CI 1.16 – 10.39) (p=0.007). If 
either the QFT or TST was positive the diagnostic accuracy was 52.0% (95 % CI 0.42 – 0.62) which is 
lower than that of TST alone although the sensitivity (91.4%; 95% CI 0.76 – 0.98) was slightly higher 
than TST alone. Specificity (32.4%; 95% CI 0.22 – 0.45), PPV (40.0%; 95% CI 0.29 – 0.52), NPV (88.5%; 
95% CI 0.69 – 0.97) and AUC (0.62; 95% CI 0.55 – 0.69) were all lower than for TST alone. Lastly, if 
both the QFT and TST were positive, patients were 3.92 times more likely to have a diagnosis of 
possible or probable IOTB than if both were negative (RR=3.29; 95% CI 2.04 – 7.52) (p<0.001). If both 
tests were positive the sensitivity (74.3%; 95% CI 0.56 – 0.87), NPV (85.2%; 95% CI 0.73 – 0.93) and 
AUC (0.74; 95% CI 0.65 – 0.83) were lower than for TST alone whereas the specificity (73.2%; 95% CI 
0.61 – 0.83), PPV (57.8%; 95% CI 0.42 – 0.72) and diagnostic accuracy (74.0%; 95% CI 0.64 – 0.81) 
were higher than for TST alone although none of these differences were statistically significant. 
Several studies have compared TST and an IGRA as diagnostic tools for the diagnosis of IOTB. In 
some instances TST was compared to T-SPOT.TB2,3 while in others it was compared to QFT.4,16 
However, none of these studies specifically considered the role of QFT and TST in diagnosing IOTB in 
HIV+ and HIV- patients.  
In our total study cohort, we demonstrated that HIV- patients were more likely to have a positive 
QFT result than HIV+ patients. Conversely we also demonstrated a trend for patients with a negative 
TST to be HIV+. Patients were more likely to test positive for both QFT and TST if they were HIV- and 
also more likely to test negative for both QFT and TST if they were HIV+. However, in the HIV+ group, 
the median CD4+ count was found to be significantly lower in patients with a negative TST than in 
those with a positive TST (156 vs 443). Similarly, also in the HIV+ group, the median CD4+ count was 
again lower in patients with a negative QFT than in those with a positive QFT (93 vs 415). This 
indicates that HIV+ status per se might not account for an increased likelihood of having a negative 
QFT and/or TST result but rather that it is linked to patients with lower CD4+ counts.Table 4 
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compares our results to those published from India7, Singapore4, Korea17 and Spain16. The largest 
study comparing the role of TST and QFT came from Singapore and found that TST alone 
demonstrated higher sensitivity (95.5%) for diagnosing IOTB than QFT alone (90.9%) while QFT alone 
had higher specificity (81.8%) compared to TST alone (72.7%).4 The study from Spain however found 
that QFT alone had a higher sensitivity and specificity than TST alone while the study from India also 
showed that TST alone (92.0%) had a higher sensitivity than QFT alone (82.0%). In our study we also 
found that the sensitivity of TST alone (90.3%) was higher than that of QFT alone (85.7%) but, in 
contrast to the other studies, the specificity of TST alone (60.3%) was also significantly superior to 
that of QFT alone (33.3%). Both South Africa and India are developing countries endemic for TB 
while the other 3 countries are not and it is interesting to note that the TST demonstrated superior 
sensitivity to that of QFT in both endemic countries. Furthermore, TST alone had a higher PPV and 
NPV (54.9% and 92.1% respectively) than QFT alone (40.5% and 81.5% respectively). If both the TST 
and QFT were positive the specificity (73.2%) was higher than if the TST alone was positive but this 
difference was insignificant. 
In our study, the subgroup diagnosed with IOTB consisted of 24 HIV- patients (68.4%) and 11 HIV+ 
patients (31.4%) with the latter having a median CD4+ count of 249 x 106/L (range 809 x 106/L). Four 
of the 11 HIV+ patients had a CD4+ count of <75 x 106/L which in most instances would lead to a 
false negative TST and QFT result. In our opinion these HIV+ patients with very low CD4+ counts 
could account for the lower sensitivity of both TST and QFT in our study as compared to those 
reported by Ang et al.4 We also found that TST alone had a higher specificity than QFT alone which 
indicates that in our highly endemic setting the QFT test produced too many false positive results. 
Positive predictive values for TST and QFT alone were lower than those reported from areas with 
lower prevalence of TB but the NPV of TST and QFT were much higher than those reported from 
elsewhere. The 92.1% NPV of TST alone shows that, in our setting, a negative TST result allows the 
clinician to exclude IOTB in HIV+ and HIV- patients with a high degree of certainty although we must 
bear in mind that a negative TST result in a patient with a CD4+ count <100 x 106/L should be 
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considered with caution. The NPV of QFT alone was more than 10% lower than that of TST alone and 
therefore it seems that the extra cost of QFT testing to exclude IOTB cannot be justified in a limited 
resource environment as found in many developing countries. According to our data the only 
possible advantage of doing a QFT in addition to a TST is that if both tests are positive the specificity 
increases to 73.2% compared to 60.3% of TST alone and 33.3% of QFT alone but given that this 
difference is not statistically significant it remains uncertain whether this questionable benefit 
warrants the extra cost. 
One potential limitation of our study is that the number of participants in our IOTB subgroup was 
quite small and subsequently we could not demonstrate statistically significant differences between 
sensitivity and specificity of TST and QFT in HIV+ and HIV- patients for detection of possible or 
probable IOTB. Further studies should be undertaken to determine how these tests perform in HIV+ 
and HIV- patients respectively. 
Conclusion 
Our study demonstrated that both TST, and to a lesser extent QFT, play a valuable role in the 
diagnosis of IOTB, even if a patient has HIV infection. However, once the CD4+ count drops to <100 x 
106/L a negative result for either test should be considered with caution. In limited resource settings 
encountered in many developing countries it is doubtful whether the slight benefit of QFT testing in 
addition to TST justifies the extra expense. 
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Figure 1 QuantiFERON and tuberculin skin test results 
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Stellenbosch University  https://scholar.sun.ac.za
58 
 
Figure 2: CD4 counts of HIV+ patients with positive and negative QFT results
 
Figure 3: CD4 counts of HIV+ patients with positive and negative TST results 
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Table 1: Summary of special investigations performed 
Baseline investigations in all cases 
 
• HIV (& CD4 count if indicated) 
• Full blood count (FBC) 
• Erythrocyte sedimentation rate (ESR) 
• Rapid plasma reagin (RPR) and Treponema pallidum antibodies (TPAbs) 
• Creatinine 
• Serum angiotensin converting enzyme (sACE) 
• Dipstick urinalysis 
• Chest X-ray (CXR) 
• Tuberculin skin test (TST) 
• Quantiferon-TB Gold (QFT) 
 
Other investigations if indicated 
 
• Chest CT (standard or high resolution) 
• PET/CT 
• HLA-B27 
• Anti-Streptolysin O titer (ASOT) 
 
Second-line investigations (if baseline tests negative) 
 
• Anterior chamber tap for: 
o PCR for herpesvirus 1 – 6, rubella, toxoplasma 
o GWC for HSV, VZV, CMV and toxoplasma 
o Mycobacteria Growth Indicator Tube (MGIT) and IS6110 TB PCR (if ocular TB 
suspected) 
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Table 2 Demographics and anatomical classification of uveitis in study participants 
 
Table 3: Comparison of accuracy between QFT, TST and combinations thereof 
 
Characteristics All (n=35) Positive (n=30) Negative (n=5) p-value
Age, years (±SD) 38.7 (13.4) 33.5 (19.1) 36.2 (8.2) 0.66
HIV+ 36.0 (11.0) 31.7 (2.9) 0.53
HIV- 40.3 (15.2) 43.0 (9.9) 0.81
Gender (%) 1
Male 14 (40.0) 12 (40.0) 2 (40.0)
Female 21 (60.0) 18  (60.0) 3 (60.0)
Laterality (%) 1
Unilateral 18  (51.4%) 15 (50.0) 3 (60.0)
Bilateral 17  (48.6%) 15 (50.0) 2 (40.0)
Anatomic distribution (%) 0.68
Anterior 19 (54.3) 17 (56.7) 2 (40.0)
Posterior 1 (2.8) 1 (3.3) 0 (0)
Panuveitis 15 (42.9) 12 (40.0) 3 (60.0)
HIV status (%) 0.14
Positive 11 (31.4%) 8 (26.7) 3 (60.0)
Negative 24 (68.6%) 22 (73.3) 2 (40.0)
QFT result
Features of diagnostic tests
QFT TST QFT or TST QFT & TST
Sensitivity 85.7% (0.69, 0.95) 90.3% (0.73, 0.97 91,4% (0.76, 0.98) 74.3% (0.56, 0.87)
Specificity 33.3% (0.23, 0.46) 60.3% (0.47, 0.73) 32.4% (0.22, 0.45) 73.2% (0.61, 0.83)
Positive predictive value 40.5% (0.29, 0.53) 54.9% (0.40, 0.69) 40.0% (0.29, 0.52) 57.8% (0.42, 0.72)
Negative predictive value 81.5% (0.61, 0.93) 92.1% (0.78, 0.98) 88.5% (0.69, 0.97) 85.2% (0.73, 0.93)
Positive likelihood ratio 1.29 (1.03, 1.6) 2.28 (1.62, 3.19) 1.35 (1.12, 1.64) 2.78 (1.80, 4.27)
Negative likelihood ratio 0.43 (0.18, 1.03) 0.16 (0.05, 0.48) 0.26 (0.08, 0.82) 0.35 (0.20, 0.63)
Risk ratio 2.19 (0.95, 5.06) 6.95 (2.28, 21.19) 3.47 (1.16, 10.39) 3.92 (2.04, 7.52)
Accuracy 51.0% (0.41, 0.61) 71.0% (0.60, 0.80) 52.0% (0.42, 0.62) 74.0% (0.64, 0.81)
AUC 0.60 (0.51, 0.68) 0.75 (0.67, 0.84) 0.62 (0.55, 0.69) 0.74 (0.65, 0.83)
Abbreviations : CI - confidence intervals; QFT - Quantiferon; TST - Tuberculin skin test; AUC - area under curve
Positive test result, (95%CI)
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Table 4: Combination of sensitivity and specificity of Quantiferon and TST in different countries 
 
South Africa India Singapore Korea Spain 
TB incidence/100 000 834 217 44 80 12 
Sensitivity Q+  85.70% 82.00% 90.90% 100.00% 90.90% 
Sensitivity T+ 90.30% 92.00% 95.50% N/A 87.80% 
Sensitivity Q+T+ 74.30% 74.00% 73.30% N/A 78.70% 
Specificity Q+ 33.30% 76.00% 81.80% 72.00% 82.80% 
Specificity T+ 60.30% N/A 72.70% N/A 78.50% 
Specificity Q+T+ 73.20% 95% 88.20% N/A 78.50% 
PPV Q+ 40.50% N/A 90.90% 16.7 - 51.7% 71.40% 
      Abbreviations: Q+ = Quantiferon positive; T+ = TST positive; Q+T+ = Quantiferon and TST positive;  
PPV = positive predictive value; N/A = not available 
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Abstract 
Purpose: To use polymerase chain reaction (PCR) and Goldmann-Witmer Coefficient (GWC) 
calculation to search for evidence that Epstein-Barr virus (EBV) causes uveitis. 
Methods: A prospective cross-sectional study where participants with positive multiplex EBV PCR 
results were further investigated by: 1) real-time PCR for EBV viral loads (VL) and 2) EBV GWC. 
Results: Eleven of 106 consecutive uveitis patients (10.4%) had positive multiplex PCR for EBV on 
aqueous humor sampling and 7/11 (63.6%) were HIV-positive. Only 4/10 (40%) cases had detectable 
intraocular EBV VLs which were always lower than the blood or plasma VL.  EBV GWC was negative 
in all 10 cases tested. In 9/11 (81.8%) of these cases an alternative, more plausible cause of uveitis 
was identified. 
Conclusion: We found no evidence of active intraocular replication or antibody production to prove 
that EBV caused uveitis in these cases. In most cases an alternative treatable cause of uveitis was 
identified. 
Keywords: polymerase chain reaction; Goldmann-Witmer coefficient; Epstein-Barr virus; uveitis 
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Introduction 
Epstein-Barr virus (EBV), also known as human herpes virus 4 (HHV-4), forms part of the group of 
human herpes viruses. EBV is a ubiquitous virus and the vast majority of adults will show evidence of 
prior infection. EBV has been strongly linked to a variety of diseases including nasopharyngeal 
carcinoma, Burkitt’s lymphoma, Hodgkin’s lymphoma and infectious mononucleosis.1,2 In the past, 
several attempts have been made to implicate EBV as a cause of uveitis but the diagnosis was often 
only substantiated by the demonstration of antibodies against EBV in serum and/or aqueous humor 
(AH).3,4 To date, evidence to support a possible role for EBV in the pathogenesis of uveitis is limited. 
Yamamoto and co-workers, using multiplex polymerase chain reaction (PCR) for HHV 1 - 8, detected 
EBV DNA in 17 out of 60 ocular fluid samples.5 Only 3 of these samples showed high copy numbers 
(6.6 x 103; 2.4 x 108 and 7.3 x 103 copies/ml respectively) of EBV DNA when using real-time PCR. 
Unfortunately they did not report the EBV viral loads (VL) in the blood at the time of taking the 
ocular samples, so one cannot determine whether the viral load in the blood was higher or lower 
than in the eye. In another report, in-situ hybridization studies of a retinal biopsy specimen were 
positive for EBV but the virus was located in atypical lymphoid cells infiltrating the retina and not the 
retinal cells themselves.6 Only one report was able to demonstrate cells reacting with antibodies 
against cytomegalovirus (CMV) and EBV in the ganglion cell layer and inner granular layer of the 
retina using double immunostaining techniques.7 The authors could however not prove whether EBV 
was causing the retinitis or whether it just happened to be present in the retinal tissue. On the other 
hand, Ongkosuwito and co-workers provided evidence showing that EBV does not play an important 
role in the pathogenesis of intraocular inflammation.1 They found only 3 patients with evidence of 
local antibody production by Goldmann-Witmer coefficient (GWC) determination in the eye out of 
82 patients tested. Two of these patients had borderline positive GWCs and the other had uveitis 
caused by varicella-zoster virus (VZV). Furthermore, none of these 3 patients had detectable 
intraocular EBV DNA. They found detectable EBV DNA in 6 out of 11 HIV negative 
immunocompromised patients but 4 of these 6 patients had another more plausible cause for their 
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uveitis (two patients had CMV retinitis, one had toxoplasma chorioretinitis and one had VZV acute 
retinal necrosis). Similarly, in a more recent report EBV PCR was positive in 3 patients of which 2 
were known to have Toxoplasma chorioretinitis and the other had uveitis of unknown cause. All 3 
patients had negative GWC for EBV and the authors concluded that more studies using a 
combination of PCR and GWC were required.8 Lau and co-workers detected EBV in 3 of 18 eyes 
(16.7%) with acute retinal necrosis but in all 3 cases VZV was also present in the same eye and 
assumed to ultimately be the cause of the retinal necrosis.9 Other authors have discussed various 
ocular conditions that may be associated with EBV but conclude that, apart from a dendritic keratitis 
from which EBV was cultured, there is little evidence that EBV causes intraocular inflammation.10,11 
In an earlier paper we reported that in our setting HIV positive patients with uveitis were more likely 
to test positive for EBV by multiplex PCR than HIV negative patients.12 We were however unable to 
measure intraocular viral loads of EBV at that time and could not determine whether significant 
intraocular viral replication was responsible for the uveitis. We subsequently designed a prospective 
study whereby we were able to determine intraocular viral loads of EBV by real-time PCR after we 
obtained a positive multiplex PCR for EBV as a screening test. In addition, GWC analysis to 
demonstrate intraocular antibody production against EBV was performed. 
Materials and methods 
Study participants  
Between February 2014 and July 2015 we conducted a prospective study including consecutive 
patients with either a new diagnosis of uveitis or a diagnosis of chronic uveitis with unknown cause. 
Patients were excluded if they: 1) were under 18 years old, 2) had uveitis with known or clinically 
obvious cause and 3) declined consent to HIV testing after appropriate counselling. A total of 106 
patients who presented to the Eye Clinic at Tygerberg Hospital, a tertiary referral hospital serving the 
eastern Metropole of Cape Town, South Africa were enrolled after informed consent was obtained. 
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The study was approved by Stellenbosch University Health Research Ethics Committee (Ref no 
N13/10/146) and adhered to the tenets of the Declaration of Helsinki. 
Investigations 
All participants underwent extensive investigation to look for the underlying cause of the ocular 
inflammation as previously described.13 Blood tests included HIV status (plus CD4+ lymphocyte count 
if positive), rapid plasma reagin (RPR), Treponema pallidum antibodies, serum angiotensin 
converting enzyme levels, full blood count, erythrocyte sedimentation rate, creatinine levels as well 
as HLA-B27 testing and anti-Streptolysin O titers if clinically indicated. Dipstick urinalysis and chest 
radiograms were obtained in all cases while chest CT scans (standard or high-resolution) and PET/CT 
scans were ordered if considered necessary after consultation with a specialist pulmonologist. 
In cases where baseline tests were negative, anterior chamber (AC) taps were performed as second-
line investigations. AH samples underwent qualitative multiplex PCR testing for human herpes 
viruses 1 – 6, rubella virus and Toxoplasma at the National Health Laboratory Services (NHLS) 
Medical Virology laboratory, Tygerberg Hospital, Cape Town, South Africa as previously described.12 
In addition, GWC for herpes simplex virus, varicella-zoster virus, CMV, rubella virus and Toxoplasma 
were performed at the University Medical Center Utrecht, the Netherlands.14,15 If a positive 
multiplex PCR result for EBV was recorded then a second AH sample was taken from the affected 
eye for quantitative PCR to determine the EBV VL in the eye. At the time of performing the second 
AC tap we also obtained an anticoagulated peripheral blood sample to measure the EBV VL in the 
plasma and/or whole blood. EBV VL measurements on both AH and plasma/blood were performed 
by the NHLS laboratory, Groote Schuur Hospital, Cape Town using EBV R-gene® Quantification assays 
(bioMérieux, Marcy l'Etoile, France). In cases with a positive EBV PCR, EBV GWC was determined if 
sufficient sample volumes were available. EBV IgG was measured in serum and aqueous humor by 
analysing four two-fold serial dilutions starting at 1:101 and 1:50.5, respectively, using the 
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Virion\Serion classic Epstein-Barr Virus VCA IgG kit (Würzburg, Germany). The GWC was calculated 
as described previously.15  
Results 
Demographics and clinical findings 
A total of 106 participants were included in the prospective study and 11 (10.4%) of these tested 
positive for EBV by multiplex PCR on AH (Table 1). In this paper we only describe the demographics 
and clinical findings of the subgroup of 11 EBV positive cases. Seven of the 11 cases were of mixed 
ethnicity and the remaining 4 cases were black Africans. Seven of the 11 (63.6%) EBV positive cases 
also had HIV infection with a median CD4+ count of 181 x 106/L. In our previous study we found an 
even higher proportion of EBV positive cases to also have HIV infection (10/12, 83.3%) (p=0.026).12 
The mean age of EBV positive cases was 37.0 ± 8.93 years and 6 (54.5%) were males. Unilateral 
involvement (7/11, 63.6%) was more common than bilateral involvement (4/11, 36.4%) and anterior 
uveitis (7/11, 63.6%) was the most common type of uveitis followed by panuveitis (3/11, 27.3%) and 
intermediate uveitis (1/11, 9.1%). Granulomatous uveitis was noted in 3 cases only.  
Quantitative PCR and GWC results 
Quantitative PCR was subsequently performed on aqueous humor from 10 eyes, plasma from 7 
individuals and whole blood from 4 individuals (Table 1). In aqueous humor the EBV VL was above 
the detectable limit (180 copies/mL) in only 4 cases (40%). In plasma the EBV VL was above the 
detectable limit in only one case (14.3%) and in whole blood in all 4 cases (100%). In 3 of the 4 cases 
where EBV VL was detectable in aqueous humor the EBV VL in the eye was lower than that 
measured in whole blood and in the fourth case the EBV VL in whole blood was not measured. EBV 
GWC was calculated in 10 of the EBV PCR positive patients (90.9%). All 10 patients were seropositive 
for EBV while EBV IgG antibodies were detected in 8 of 10 AH samples. However, none of these 
cases had a positive GWC for EBV (Table 2).  
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Furthermore, in 9 of the 11 cases (81.8%) another more plausible cause of intraocular inflammation 
was identified (Table 1). Syphilitic uveitis was diagnosed in two cases, possible ocular tuberculosis 
(TB) was diagnosed in two cases and there was one case each of post-streptococcal uveitis, CMV 
retinitis, VZV/HSV co-infection and HLAB27 positive acute anterior uveitis. One case was diagnosed 
with HIV-associated uveitis and here, in contrast to the EBV VL in the eye, the HIV VL of the AH was 
more than 150 times higher than the HIV VL in the blood which implies HIV replication inside the 
eye.16 The two remaining cases were labelled as idiopathic despite having positive EBV PCR as both 
had a low EBV VL and negative EBV GWC. 
Discussion 
To date there is very little convincing evidence in the ophthalmic literature to support an active role 
for EBV in the pathogenesis of uveitis. Only one case could demonstrate EBV in retinal cells but CMV 
was also present in the same specimen.7 In our prospective study using a combination of multiplex 
and real-time PCR for EBV we did not find a single case where EBV VL was significantly higher in the 
eye than in the blood or plasma which would appear to indicate that EBV replication was not actively 
taking place inside the eye. In the cases where EBV VL could be compared between the eye and the 
blood it was found that the VL in the blood was considerably higher than in the eye. This appears to 
support the leakage theory whereby it is assumed that EBV cell free or present in lymphocytes in the 
bloodstream enters the eye when the blood-eye barriers break down as a result of ocular 
inflammation caused by some other trigger. Alternatively, but not mutually exclusive, in the course 
of uveitis specific lymphocytes latently infected with EBV may be attracted to the inflamed eye, 
which could give rise to positive PCR results on AH. 
In our case series an alternative and more plausible cause of uveitis was found in over 80% of cases. 
Furthermore, the finding that in our setting almost two thirds of EBV positive cases had concomitant 
HIV infection also raises questions. One possible explanation could be that HIV infection per se 
increases vascular permeability and allows EBV and EBV-infected lymphocytes to leak into the eye 
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although further research is required to establish whether this is indeed the case. It has been 
postulated that EBV may influence the course of intraocular inflammation due to other causes such 
as toxoplasma or the other herpes viruses by producing an active homologue of interleukin-10 and 
therefore playing a secondary role in the pathogenesis of uveitis.1 
Measurement of EBV IgG levels in serum and AH produced two interesting findings. Firstly, serum 
EBV IgG levels were much higher than those in the AH in all 10 cases and secondly, no local antibody 
production could be demonstrated inside the eye as the GWC was negative in all cases. A 
concentration gradient was therefore present between high IgG levels in the blood and lower (or 
non-detectable) levels inside the eye. We hypothesize that once the permeability of the blood-
aqueous barrier separating the two compartments increased due to inflammation then diffusion of 
the IgG could take place along that gradient. 
A possible limitation of this study is the small sample size and future studies should therefore seek to 
include a larger sample size. However, to the best of our knowledge, this is the first prospective 
report that utilized both qualitative and quantitative PCR as well as GWC to study the role of EBV in 
uveitis in HIV+ and HIV- patients. 
Conclusion 
Given that we found no evidence of either EBV replication or increased local antibody production in 
the eye and that in most cases a more plausible cause of inflammation was found we currently 
conclude that EBV is unlikely to be the perpetrator. EBV may still turn out to be an accomplice or 
even the cause in some cases of uveitis, but is probably just an innocent bystander in the majority of 
cases. Qualitative PCR on intraocular fluid and/or blood serology alone are not sufficient to 
conclusively establish a diagnosis of an intraocular infection with EBV. Additional diagnostic tools, 
such as EBV VL on AH and plasma as well as EBV GWC, are required to determine whether EBV plays 
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a significant role in any given case of uveitis and we therefore propose a stepwise approach to 
making or excluding a diagnosis of EBV-associated uveitis (Table 3). 
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Table 1: Demographics, clinical finding and final diagnoses in patients with positive EBV PCR 
Pt no HIV CD4 Final diagnosis Explanation 
1 Neg N/R Idiopathic EBV VL not significant 
2 Pos 483 Idiopathic EBV VL not significant 
3 Neg N/R Possible ocular TB  Meets criteria & TST positive 
4 Pos 414 Poststreptococcal Raised Anti Dnase 
5 Pos 184 VZV/HSV coinfection VZV GWC = 48.45 & HSV GWC = 6.71 
6 Pos 138 Syphilis RPR = 1:512 
7 Pos 121 HIV uveitis HIV VL eye >> HIV VL blood 
8 Neg N/R Possible ocular TB Meets criteria and TST and QFT both positive 
9 Pos 181 Syphilis  RPR = 1:16 
10 Neg N/R HLAB27 HLAB27+ with typical phenotype 
11 Pos 86 CMV Frosted branch angiitis and CMV PCR+ 
 
Abbreviations: Anat distrib = anatomical distribution; Granul = Granulomatous; VL = viral load; N/R = 
not relevant; N/A = not available; LDL = lower than detectable limit; TST = tuberculin skin test; QFT = 
Quantiferon TB Gold; RPR = rapid plasma reagin  
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Table 2: EBV viral loads and EBV GWC results 
 
 
Pt no EBV VL eye (cps/ml) EBV VL plasma (cps/ml) EBV VL blood (cps/ml) Se EBV IgG (IU/ml) AH EBV IgG (IU/ml) EBV GWC
1 692 LDL N/A 68.4 <4 <3
2 LDL LDL N/A 339.2 179.5 1.31
3 LDL LDL N/A 1172.8 97.8 0.86
4 LDL LDL N/A 2256.8 28.4 0.35
5 LDL LDL N/A 211 <4 <3
6 8258 LDL 25650 866.6 42 0.28
7 LDL 15797 N/A 3148 6.1 0.28
8 LDL N/A 82 100.8 13.8 <3
9 678 N/A 85133 3273.6 698.8 0.43
10 N/A N/A N/A 125.7 66.6 0.87
11 186 N/A 91424 N/A N/A N/A
Abbreviations: VL = viral load; cps/ml = copies per milliliter; IU/ml = international units per milliliter; Se = serum; AH = aqueous humor
LDL = lower than detectable limit; N/A = not available
Abbreviations: IGRA = Interferon Gamma Release Assay; AC = anterior chamber; mPCR = multiplex PCR; VL = viral load
Table 3: Stepwise approach to diagnose EBV uveitis
New, chronic or recurrent uveitis case 
of unknown cause
Baseline investigations:
HIV, syphilis serology, sACE, urine dipstick
CXR, Mantoux/IGRA, CT chest if indicated
Positive findings:
Manage accordingly
Negative findings:
Requires further investigation
AC/vitreous tap 
for mPCR
Positive for HSV, VZV, CMV, 
Rubella, Toxoplasma
EBV VL Eye > plasma or EBV GWC
Positive for EBV
Negative Positive
EBV uveitisIdiopathic
Stellenbosch University  https://scholar.sun.ac.za
73 
 
References: 
1. Ongkosuwito JV, Van der Lelij A, Bruinenberg M, et al. Increased presence of Epstein–Barr virus 
DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis. Br J 
Ophthalmol. 1998;82(3):245-251.  
2. Kim SJ, Barañano DE, Grossniklaus HE, Martin DF. Epstein-Barr infection of the retina: Case report 
and review of the literature. Retinal Cases and Brief Reports. 2011;5(1):1-5.  
3. Usui M, Sakai J. Three cases of EB virus-associated uveitis. Int Ophthalmol. 1990;14(5-6):371-376.  
4. Kramer S, Brummer C, Zierhut M. Epstein–Barr virus associated acute retinal necrosis. Br J 
Ophthalmol. 2001;85(1):110-110.  
5. Yamamoto S, Sugita S, Sugamoto Y, Shimizu N, Morio T, Mochizuki M. Quantitative PCR for the 
detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis. Jpn J 
Ophthalmol. 2008;52(6):463-467.  
6. Hershberger VS, Hutchins RK, Witte DP, Schneider S, Harris RE, McGonegle SJ. Epstein-Barr virus-
related bilateral acute retinal necrosis in a patient with X-linked lymphoproliferative disorder. Arch 
Ophthalmol. 2003;121(7):1047.  
7. Freigassner P, Ardjomand N, Radner H, El-Shabrawi Y. Coinfection of the retina by Epstein-Barr 
virus and cytomegalovirus in an AIDS patient. Am J Ophthalmol. 2002;134(2):275-277.  
8. de Groot-Mijnes JDF, de Visser L, Zuurveen S, et al. Identification of new pathogens in the 
intraocular fluid of patients with uveitis. Am J Ophthalmol. 2010;150(5):628-636.  
9. Lau CH, Missotten T, Salzmann J, Lightman SL. Acute retinal necrosis features, management, and 
outcomes. Ophthalmology. 2007;114(4):756-762.  
Stellenbosch University  https://scholar.sun.ac.za
74 
 
10. Wilhelmus KR. Ocular involvement in infectious mononucleosis. Am J Ophthalmol. 
1981;91(1):117-118.  
11. Matoba AY. Ocular disease associated with Epstein-Barr virus infection. Surv Ophthalmol. 
1990;35(2):145-150.  
12. Laaks D, Smit DP, Harvey J. Polymerase chain reaction to search for herpes viruses in uveitic and 
healthy eyes: A South African perspective. Afr Health Sci. 2015;15(3):748-754.  
13. Smit DP, Esterhuizen TM, Meyer D. The prevalence of intraocular tuberculosis in HIV-positive and 
HIV-negative patients in South Africa using a revised classification system. Ocul Immunol Inflamm. 
2016:1-8.  
14. Kongyai N, Pathanapitoon K, Sirirungsi W, Kunavisarut P, de Groot-Mijnes JDF, Rothova A. 
Infectious causes of posterior uveitis and panuveitis in Thailand. Jpn J Ophthalmol. 2012:1-6.  
15. De Groot-Mijnes JD, Rothova A, Van Loon AM, et al. Polymerase chain reaction and goldmann-
witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J 
Ophthalmol. 2006;141(2):313-318.  
16. Pathanapitoon K, Riemens A, Kongyai N, et al. Intraocular and plasma HIV-1 RNA loads and HIV 
uveitis. AIDS. 2011;25(1):81-86.  
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
75 
 
Chapter 7: Correspondence – published in the journal “AIDS” 
Citation: 
Smit DP, Meyer D. HIV-induced uveitis: would you recognize it if it looked straight at you? AIDS. 
2017 Jul 31;31(12):1777-9. 
DOI: 10.1097/QAD.0000000000001564 
Introduction 
According to the World Health Organization, the number of people of all ages living with HIV 
infection in South Africa was 7 million in 2015 which translates to a prevalence of 19.2% amongst 
individuals aged 15 years and older. The number of new infections reported in South Africa during 
2015 was 380 000 with 180 000 deaths attributed to AIDS during the same period.1 More than 3.3 
million (48.0%) people living with HIV received highly active antiretroviral therapy (HAART) during 
2015 and this appears to be slowly turning the tide against the HIV pandemic in the country. 
Despite recent gains in the battle against HIV/AIDS, South Africa remains one of the countries with 
the highest prevalence of this disease in the world and intermittently an unusual clinical 
presentation is encountered that must be shared with clinicians who work with patients living with 
HIV. HIV-induced uveitis is such a condition. 
Case report 
A 44 year old male presented to the Eye Clinic at Tygerberg Academic Hospital in Cape Town with a 3 
week history of redness and progressive vision loss in his right eye. He had no previous ocular or 
medical history of note. On examination his uncorrected visual acuity was decreased in both eyes. 
The right eye read 0.6 and the left eye 0.5 on a decimal Snellen chart. Both eyes showed mild 
circumcorneal injection and large keratic precipitates on the endothelium (Figure 1a). Inflammatory 
activity was noted in the anterior chambers and the anterior vitreous humor of both eyes. In both 
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eyes small fluffy nodules were prominent all along the pupil margin (Figure 1b). The rest of the eye 
examination was normal. Topical corticosteroid therapy was commenced to address the 
inflammation while special investigations were being performed. 
Routine first-line investigations were requested to search for the underlying cause of the uveitis. 
These included a full blood count, erythrocyte sedimentation rate, creatinine, syphilis serology as 
well as serum angiotensin converting enzyme level and all had negative results. An HIV test was 
requested after obtaining informed consent.  The patient was newly diagnosed with HIV infection 
with a CD4+ cell count of 121 x 106/L. Chest radiography was normal and dipstick urinalysis revealed 
1+ protein only. A tuberculin skin test (17mm) and QuantiFERON-TB Gold test (1.59) were both 
positive but subsequent high-resolution chest computed tomography (CT) scan was normal making a 
diagnosis of intraocular tuberculosis unlikely. A 0.1mL sample of aqueous humor (AH) was obtained 
from the right anterior chamber and tested by multiplex PCR for herpes viruses 1 -6. The qualitative 
multiplex PCR was positive for Epstein-Barr virus (EBV) although a quantitative PCR showed that the 
EBV viral load (VL) was lower than the detectable limit and therefore also unlikely to be the cause of 
the inflammation.  
Since the intraocular inflammation was not improving on topical corticosteroid treatment, a second 
paired AH and blood sample was obtained to determine the HIV VL in the ocular fluid and blood. The 
HIV VL in the blood was 215 810 copies/mL while the HIV VL in the AH was 35 724 280 copies/mL 
thereby demonstrating that the virus had been replicating inside the eye. This was regarded as 
convincing evidence for  the diagnosis of HIV-induced uveitis. The patient was commenced on first-
line HAART and the inflammation subsided within three weeks without any further corticosteroid 
treatment and has remained asymptomatic for more than 30 months. 
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Discussion  
It is well known that HIV infection predisposes patients to a wide range of opportunistic infections 
that may also involve the eye and cause intraocular inflammation.2,3 The notion that HIV infection 
per se may also cause intraocular inflammation has been entertained since the late 1980’s but 
laboratory evidence to support this hypothesis was lacking for many years and the diagnosis was 
initially based on a positive response to zidovudine monotherapy.4 In 1998, Rosberger et al cultured 
HIV from the AH of 3 eyes and vitreous humor of 1 eye suspected of having HIV-induced uveitis.5 In 
2008, Rothova et al demonstrated that a patient with HIV-induced uveitis had an intraocular HIV-1 
RNA viral load which was several times higher than that in the plasma thus indicating that HIV can 
locally replicate inside the eye and cause inflammation.6 
Subsequent reports from Thailand helped to elucidate the clinical manifestations characteristic of 
HIV-induced uveitis.2,7 Kunavisarut et al found that all patients presented with decreased visual 
acuity and that none were receiving HAART at the time of diagnosis.2 On clinical examination none of 
the patients had conjunctival hyperemia despite all having anterior uveitis with characteristic keratic 
precipitates on the corneal endothelium. Furthermore, no retinal lesions or scars were noted and no 
clinical evidence suggestive of opportunistic infections was found. Laboratory investigations also did 
not provide any evidence of opportunistic infections and in all cases the intraocular HIV load was 
found to be much higher than the plasma HIV load although in some instances the inflammation was 
present for 2 years before the diagnosis was confirmed. None of the patients responded to topical 
and/or systemic corticosteroid therapy but in all cases complete resolution of the intraocular 
inflammation occurred after administration of HAART. The case described in this paper therefore 
matches every aspect of this description but also includes a previously unreported finding of small 
fluffy nodules along the pupil margin. Interestingly, the patients described in both 1988 and 1998 
also show significant similarities to these cases.4,5 The concept of HIV-induced uveitis has therefore 
existed for almost 30 years and yet many health care practitioners, including ophthalmologists, who 
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work with patients living with HIV are unaware of this condition. In contrast, most health workers 
are well aware of the opportunistic ocular infections and inflammation associated with HIV infection. 
It is therefore important to bring HIV-induced uveitis to the attention of everyone working in the 
field of HIV medicine in order to ensure that the condition is suspected, diagnosed and treated 
correctly before any permanent ocular damage occurs. 
Legends: Figure 1a: Large keratic precipitates on the corneal endothelium (arrow). Figure 1b: Small 
fluffy nodules all along the pupil margin (arrows) 
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Abstract 
Purpose: To use polymerase chain reaction (PCR) and Goldmann-Witmer coefficient (GWC) 
calculation to diagnose infectious uveitis  
Methods: Prospective cross-sectional study 
Results: Twenty-seven of 106 patients (25.5%) had positive PCR and/or GWC results on aqueous 
humor (AH) sampling and 15 of 27 (55.6%) were HIV-positive. Patients with non-anterior uveitis 
(NAU) were more likely to be HIV+ (p=0.005). More than 1 possible pathogen was identified in 9 of 
27 patients (33.3%) of whom 7 (77.7%) were HIV+. The final clinical diagnosis was discordant with AH 
findings in 9 of 27 cases (33.3%). A positive EBV PCR result was associated with a discordant 
diagnosis (p=0.001). All cases of herpetic anterior uveitis (42.9% HIV+) tested PCR-/GWC+ while all 
cases of herpetic NAU tested PCR+/GWC- (83.3% HIV+). All rubella virus cases were PCR+/GWC+. 
Conclusion: PCR is useful to diagnose herpetic NAU in HIV+ patients while GWC is useful to diagnose 
herpetic anterior uveitis. 
 
Keywords: 
Polymerase chain reaction; Goldmann-Witmer coefficient; diagnosis; infectious uveitis; HIV; South 
Africa 
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Introduction 
South Africa is in the unique position of having the highest prevalence of both HIV infection and 
tuberculosis (TB) of any country in the world.1 It is therefore not surprising that the prevalence of 
intraocular TB in South Africa has recently been reported to be as high as 33.0% in the Western Cape 
Province.2 As in other developing countries, South Africa also has a high burden of other infectious 
causes of intraocular inflammation. Ocular syphilis, for example, is well known to occur more 
frequently in areas with a high prevalence of HIV infection.3 
In some instances, the laboratory diagnosis of infectious uveitis is largely based on positive blood 
serology with examples including syphilis (Treponema pallidum) and cat scratch disease (Bartonella 
henselae). In other cases however positive blood serology is neither sensitive nor specific enough to 
confidently confirm an infectious cause of uveitis. Examples here would include herpes viruses such 
as Herpes Simplex virus 1 & 2 (HSV), Varicella-Zoster virus (VZV) and cytomegalovirus (CMV) as well 
as protozoa such as Toxoplasma gondii . Over the past decade, the emphasis in the latter cases has 
shifted towards the use of molecular biology techniques to examine ocular samples either in 
isolation or in combination with blood samples.  Polymerase chain reaction (PCR) was the first 
molecular technique that came into widespread use during the previous decade.4-12 However, it later 
became apparent that PCR alone could yield false negative results under certain conditions and that 
a combination of PCR and Goldmann-Witmer coefficient (GWC) testing to detect intraocular 
antibody production was superior to either test alone.13-15  
The first molecular test to become readily available at our institution was a multiplex PCR that 
analysed for the presence of herpes viruses 1 – 6. In an earlier paper we reported a 47.2% positive 
yield with multiplex PCR in patients presenting with undifferentiated uveitis and in this group a 
positive PCR yield correlated significantly with HIV infection, posterior uveitis and duration of 
symptoms less than 30 days.16 We hypothesized that if GWCs are determined in addition to PCR 
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testing one would then be able to diagnose infectious causes of uveitis in a wider spectrum of cases.  
We present the findings of the ensuing study in this report. 
Materials and methods 
Study participants and management 
A prospective study was conducted at the Eye Clinic of Tygerberg Hospital, a tertiary referral hospital 
serving the Eastern Metropole of Cape Town, South Africa. Between February 2014 and July 2015 a 
total of 106 consecutive patients presenting with either a new diagnosis of uveitis or chronic uveitis 
of unknown cause were enrolled. Informed consent was obtained from all participants and the study 
was approved by the Health Research Ethics Committee of Stellenbosch University (Ref no 
N13/10/146). The study adhered to the tenets of the Declaration of Helsinki. Exclusion criteria were: 
1) age under 18 years, 2) uveitis of known cause and 3) declined HIV testing after appropriate 
counselling. All participants verbally completed a detailed systemic uveitis questionnaire followed by 
a comprehensive ocular examination and a tailored panel of special investigations. 
Investigations 
All participants underwent extensive special investigations to search for underlying causes of their 
intraocular inflammation as previously reported.2 Blood samples were obtained for HIV status (plus 
CD4+ count if positive), full blood count, erythrocyte sedimentation rate, rapid plasma reagin (RPR) 
and Treponema pallidum antibodies for syphilis, creatinine and serum angiotensin converting 
enzyme (sACE) levels. Tuberculin skin testing (TST) and QuantiFERON®-TB Gold (QFT) tests (Cellestis 
Inc., Chadstone, Victoria, Australia) were performed in 89 and 105 participants, respectively. Dipstick 
urinalysis and chest X-rays were requested in all cases. In selected cases, after consultation with a 
specialist pulmonologist, standard or high-resolution chest CT scans were requested while in other 
cases PET/CT scans were obtained if considered necessary. HLA-B27 testing was done if patients 
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presented with severe fibrinous anterior uveitis and Anti-Streptolysin O titers were performed in 
patients under the age of 40 years. 
Anterior chamber taps were performed as second-line investigations using the method described 
previously.16 Aqueous humor (AH) samples from 100 patients were subjected to PCR testing for 
herpes viruses 1 to 6, rubella virus (RV) and Toxoplasma at the National Health Laboratory Services 
(NHLS) Medical Virology laboratory, Tygerberg Hospital, Cape Town, South Africa. Paired serum and 
AH samples from 82 patients in the same cohort were sent to the University Medical Center Utrecht, 
Netherlands where Goldmann-Witmer Coefficients were determined for HSV, VZV, CMV, RV and 
Toxoplasma as previously described.13,17 
Statistical analysis 
IBM SPSS version 24 (IBM Corp. Released 2016. IBM SPSS Statistics for Windows, Version 24.0. 
Armonk, NY: IBM Corp.) was used to analyse the data, using a significance level of 0.05. Categorical 
factors were compared between groups using Pearson’s chi square test if assumptions were met, 
otherwise Fisher’s exact 2-sided tests were used. Continuous variables were tested for normality and 
if plausibly normally distributed, means were compared between two groups using independent 
samples t-tests, and if not, non-parametric equivalent tests for instance, Mann Whitney tests were 
used.  
Results 
Demographics and clinical findings 
During the study period a total of 106 consecutive participants with uveitis were enrolled of which 
66 were HIV- and 40 HIV+ with a median CD4+ cell count of 242 x 106/l [interquartile range 100 - 
501].  
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The clinical characteristics of the AH test-positive and test-negative patients with reference to their 
HIV status are summarised in Table 1. The mean age of patients with a positive PCR and/or GWC was 
39.6 ± 8.8 years and the majority were female (n=16). Both eyes were involved in 8 cases (29.6%). 
HIV testing was positive in 15 cases (55.6%) and HIV+ cases had a median CD4+ cell count of 181 x 
106/l [interquartile range 88 – 483] but showed no differences regarding age and laterality when 
compared to the HIV- group. Sixteen cases had anterior uveitis, 6 cases panuveitis and 2 cases each 
intermediate and posterior uveitis. Only 5 of 16 patients with anterior uveitis were HIV+ whilst 6 of 7 
patients with panuveitis were HIV+ and all cases with intermediate and posterior uveitis were HIV+.  
Patients with any distribution of uveitis other than anterior were therefore more likely to have HIV 
infection (p=0.005). There were no significant differences between males and females regarding age 
(p=0.59), laterality (p=0.67), HIV status (p=0.93) or distribution of inflammation (p=0.43). Eight cases 
presented with a granulomatous and 19 with a non-granulomatous appearance.  
PCR and GWC results  
The 27 patients in our study with positive ocular fluid tests produced 37 positive PCR and/or GWC 
results (Table 2). Nineteen of the 37 positive PCR and/or GWC results were from HIV+ patients. In 
the HIV+ group, 13 samples were only PCR+ and 6 samples only GWC+, while in the HIV- group 10 
samples were PCR+ and 8 samples GWC+. Four samples in the HIV- group were however PCR+ and 
GWC+ for RV. 
More than 1 possible pathogen was identified in 9 of 27 patients of whom 7 were HIV+ with a 
median CD4+ cell count of 181 x 106/l [interquartile range 130 – 292] (Table 3). In 9 of the 27 
patients with positive PCR and/or GWC results the final clinical diagnosis was either only partially 
supported by the positive result or in some cases not at all. In most instances where the final 
diagnosis was discordant with the PCR and/or GWC results the potential pathogen identified by PCR 
was EBV. In 9 of 11 EBV PCR+ cases an alternative, more plausible cause for the inflammation was 
found and 2 cases were considered to be idiopathic as EBV viral loads were lower than the 
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detectable limit. A positive EBV PCR result was therefore associated with a high likelihood of a 
discordant final diagnosis (p=0.001). In 10 of the 11 EBV PCR+ cases where sufficient sample volume 
was available EBV GWCs were calculated and these were also all negative thus providing further 
evidence that EBV was unlikely to be the cause of inflammation in these cases (in press).  
However, in 3 other cases we identified two different pathogens that are each known to cause 
uveitis on its own. In the first case (Table 3, number 14) a 44-year-old female presented with 
recurrent granulomatous anterior uveitis OU. At first presentation 4 years prior to enrolment she 
was noted to have mutton-fat keratic precipitates (KP) and Bussaca nodules OU and 2+ cells in both 
anterior chambers (ACs). Upon enrolment she had no iris nodules but again had bilateral mutton-fat 
KPs on the central cornea only which later formed large ghost KPs (Figure 1). Both eyes had IOP = 
17mm Hg and early cataracts. Her GWC for CMV was 13.72 but she also tested PCR+ for RV with a RV 
GWC = 333.07. Interestingly, despite the much lower GWC for CMV her clinical picture was much 
more in keeping with chronic anterior uveitis secondary to CMV than Fuchs’ uveitis syndrome (FUS). 
However, despite not attending follow-up visits for 2 years, her clinical picture changed over time to 
more closely resemble FUS albeit in both eyes with diffusely spread white KPs as well as small 
transparent iris nodules at both the pupillary margin (Koeppe) and on the surface of the iris 
(Busacca) as previously described (Figure 2).19 In the second case (Table 3, number 23) a 29-year-old 
female presented with mutton-fat keratic precipitates, Bussaca nodules, cells in the anterior 
chamber and vitreous humor as well as a superotemporal retinal granuloma OD. She had been on 
anti-retroviral treatment for 7 years and had a CD4+ count of 789 x 106/L. Her GWCs for Toxo and 
VZV were 5.83 and 4.80 respectively but she was lost to follow-up before definitive treatment could 
be commenced. We decided that Toxo was most likely the primary pathogen for three reasons. 
Firstly, the clinical picture was more compatible with Toxo than VZV. Secondly, the GWC was higher 
for Toxo than for VZV and thirdly, low positive VZV GWCs without any clinical characteristics of VZV 
uveitis  may occur (personal observation of JDF de Groot-Mijnes); with respect to the latter, it is 
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interesting to note  that subclinical reactivation of VZV may occur intrathecally particularly in HIV+ 
individuals. 20 
In the third case (Table 3, number 26) a 50-year-old female presented with a dense vitritis and 
anterior spillover OS. On further investigation we made a new diagnosis of HIV infection with CD4+ 
count of 400 x 106/L and found her serum RPR titer to be 1:128. CSF analysis revealed a positive 
VDRL of 1:4 and she was subsequently treated with intravenous Penicillin G for 14 days. She did 
however also have a positive AH multiplex PCR result for HSV-1 and was treated with oral acyclovir 
400mg 5 times a day for the same period after which the uveitis resolved. One therefore cannot 
determine with certainty whether or not the HSV-1 contributed significantly to her clinical picture. 
Thirteen of 27 patients had a final diagnosis of uveitis caused by one of the herpes viruses other than 
EBV (Figure 3). Seven of 13 cases had anterior uveitis and all of these cases tested GWC+ only (1 
HSV, 3 VZV and 3CMV). Conversely, 6 of 13 cases had non-anterior uveitis and here all cases tested 
PCR+ only (4 VZV and 2 CMV). In the PCR-/GWC+ anterior uveitis group only 3 of 7 cases  were HIV+ 
while in the PCR+/GWC- non-anterior uveitis group 5 of 6 cases  were HIV+. A final diagnosis of 
infectious uveitis was made in 14 of 15 HIV+ patients as follows: 1 HSV, 4 VZV, 3 CMV, 1 HIV-induced, 
3 ocular syphilis, 1 poststreptococcal and 1 Toxoplasma. On the other hand, 10 of 12 HIV- patients 
had a final diagnosis of infectious uveitis: 3 VZV, 2 CMV, 3 RV and 2 possible ocular TB. No cases of 
rubella virus were therefore seen among HIV+ patients while no cases of ocular syphilis or 
Toxoplasma were seen among HIV- patients in this subgroup. 
Discussion 
Very little is known about the aetiology of infectious uveitis in South Africa and to the best of our 
knowledge there is only one other report of the use of PCR and GWC to determine the underlying 
cause of uveitis in South African patients although that study was conducted in a rural area 2000 km 
from our metropole.18 In our area we found the prevalence of HIV infection among all patients 
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presenting with uveitis to be 37.7%. In the subgroup with a positive PCR and/or GWC result studied 
in this paper the prevalence was 55.6%. When looking at the actual samples tested it is interesting to 
note that in the HIV+ group 68.4% of samples were PCR+ while only 31.6% were GWC+. In contrast, 
in the HIV- group 55.6% of samples were PCR+ compared to 44.4% that were GWC+. This suggests 
that in HIV+ patients the pathogen detection frequency of PCR is more than twice as high as that of 
GWC whereas in HIV- patients this is not the case. To us, this implies that HIV+ cases more 
frequently present early and have actual infection whereas in HIV- patients presentation is may 
sometimes be slightly more delayed, thereby allowing time for antibody production to take place. 
Even though this finding did not reach statistical significance due to small sample size it does suggest 
that PCR may be more useful than GWC in HIV+ uveitis cases with low CD4+ cell counts. Not 
surprisingly, the majority of patients from whom >1 pathogen was identified were HIV+ with a 
median CD4+ cell count of 181 x 106/l, whereas HIV+ patients from whom ≤1 pathogen was 
identified had a median CD4+ cell count of 249 x 106/l [interquartile range 94 – 501], illustrating that 
patients become more susceptible to multiple infections as their CD4+ cell counts drop. . 
A noteworthy finding is that only 31.3% of patients with anterior uveitis were HIV+ whereas 90.9% 
with any non-anterior uveitis were HIV+ (p=0.005). This underlines the importance of HIV testing in 
patients presenting with any form of uveitis in our area but even more so in cases presenting with a 
form other than anterior uveitis. Furthermore, in a study from the Netherlands, 43 of 51 
immunocompromised patients with posterior or panuveitis were found to have an infectious 
aetiology by using a combination of PCR and GWC.21 The vast majority (49%) of those cases were 
caused by CMV followed by Toxoplasma (26%), Treponema pallidum (14%) and VZV (7%). In our 
study, VZV accounted for more cases of posterior or panuveitis in HIV+ individuals than CMV and we 
also found viral causes of anterior uveitis in HIV+ individuals with HSV, VZV, CMV and HIV itself 
accounting for one case each. It would therefore appear as though the patterns of infectious uveitis 
in immunocompromised patients differ between the two countries. In Thailand, CMV was also found 
to be the most common cause of posterior and/or panuveitis in HIV-patients whereas in our study 
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the only cause of panuveitis in an HIV+ individual was VZV while CMV was only detected in HIV- 
patients with anterior uveitis.17 The seroprevalence of CMV in The Netherlands is 45.6% while in 
Thailand it has been reported to vary from 50.0 – 93.3%.22-24 The seroprevalence of both CMV and 
VZV in the Western Cape is unknown although it has been reported to be as high as 100% in rural 
South Africans with HIV infection.25 Future research should therefore be aimed at measuring the 
seroprevalence of the different human herpes virus in the Western Cape to determine whether this 
might explain why VZV was more commonly found to cause uveitis than CMV in our study. The 
ongoing development of newer PCR techniques should in future also allow us to diagnose infectious 
uveitis more accurately. The development of multiplex PCR strip kits targeting a host of viruses, 
bacteria, fungi and parasites known to cause ocular infections is cause for optimism that our ability 
to accurately diagnose intraocular infections will continue to improve in future.26  
Possible limitations in our study include relatively small sample sizes and the fact that due to 
practical reasons we were not able to perform GWCs in as many participants as compared to PCR. 
Positive considerations are the prospective and structured nature of the study which is the first ever 
of its kind to study the causes of infectious uveitis in such detail in South Africa.  
Conclusions 
In the area we serve there are differences in the clinical presentation and underlying causes of 
infectious uveitis in patients with and without HIV infection. Infections caused by more than one 
pathogen occur more frequently in HIV+ patients with low CD4+ cell counts and in these patients 
PCR is positive more than twice as many times as GWC. In HIV- patients both PCR and GWC make 
substantial contributions to determining the underlying cause of infectious ocular inflammation. 
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Table 1 Demographic and clinical data of HIV+ and HIV- patients in ocular fluid test-positive subgroup 
Characteristics All (n=27) HIV+ (n=15) HIV- (n=12) p-value  
      
Age, years (±SD) 39.6 (8.8) 38.5 (9.4) 41.0 (8.2) 0.47  
PCR+ 37.8 (9.9)     
GWC+ 38.5 (10.1)     
      
Gender       
Male 11 6 5 0.93  
Female 16 9 7   
      
Laterality     0.23  
Unilateral 19 9 10   
Bilateral 8 6 2   
      
Anatomic distribution     0.005  
Anterior 16 5 11   
Intermediate 2 2 0   
Posterior 2 2 0   
Panuveitis 7 6 1   
      
Appearance     0.09  
Granulomatous 8 5 3   
Non-granulomatous 19 10 9   
 
 
 
 
      
Table 2: PCR and GWC results per HIV status. 
 HIV+ HIV- 
 PCR+/GWC- PCR+/GWC+ PCR-/GWC+ PCR+/GWC- PCR+/GWC+ PCR-/GWC+ 
CMV 2 0 1 0 0 2 
HSV 1 0 2 0 0 0 
VZV 3 0 2 1 0 2 
EBV 7 0 0 4 0 0 
RV 0 0 0 0 4 0 
Toxo 0 0 1 0 0 0 
HHV6    1   
Total PCR 13  10  
Total GWC  6  8 
Footnote: PCR+ = polymerase chain reaction positive; GWC- = Goldmann-Witmer coefficient negative; 
GWC+ = Goldmann-Witmer coefficient positive; PCR- = polymerase chain reaction negative; HHV6 = human 
herpesvirus 6 
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Figure 1 Large central ghost KP (white arrow) and new KP (yellow arrow) 
 
Figure 2 Koeppe nodules (white arrow) and Busacca nodules (yellow arrow) OS 
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Figure 3 Herpetic uveitis stratified by anatomical distribution and HIV status 
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Chapter 9: Original article – Submitted for publication on 12 September 2017 to Ocular Immunology 
and Inflammation. Currently under review 
The Aetiology of Intraocular Inflammation in HIV positive and HIV negative Patients at a Tertiary 
Hospital in Cape Town, South Africa 
Abstract 
Purpose: To describe the prevalence of different causes of uveitis in South Africa 
Methods: Prospective cross-sectional study 
Results: One-hundred-and-six patients were enrolled and 37.7% were HIV+. Anterior and panuveitis 
were most frequently seen. Infectious, non-infectious and idiopathic uveitis were diagnosed in 
66.0%, 17.0% and 17.0% of all cases, respectively. Eighty percent of HIV+ cases had infectious uveitis. 
Overall, intraocular tuberculosis (IOTB), herpetic and syphilitic uveitis were the commonest 
infectious causes. Sarcoidosis and HLA-B27-associated uveitis were the commonest non-infectious 
causes. In anterior uveitis, HIV+ cases most frequently had probable IOTB, syphilitic or idiopathic 
uveitis while HIV- cases had possible IOTB, idiopathic or HLA-B27-associated uveitis. In panuveitis, 
HIV+ cases mostly had syphilis, probable IOTB, Toxoplasma and varicella-zoster-virus whereas HIV- 
cases mostly had possible IOTB, sarcoidosis and idiopathic uveitis. 
Conclusion: Infectious uveitis is common in South Africa, especially amongst HIV+ patients. Causes of 
anterior and panuveitis differ between HIV+ and HIV- patients. 
Keywords: 
Etiology; causes; uveitis; infectious; non-infectious; idiopathic; HIV; South Africa; Africa 
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Introduction 
South Africa has the highest prevalence of both tuberculosis (TB) and Human immune deficiency 
virus HIV infection of any country in the world and 61% of South African TB patients are reported to 
have HIV co-infection.1 Furthermore, Sub-Saharan Africa has the highest antenatal syphilis 
prevalence of all 6 WHO world regions with South Africa and Zimbabwe featuring prominently in the 
sub-region which is not surprising given the high prevalence of HIV in these countries.2,3 To date 
there has been a disconcerting shortage of literature describing the patterns of uveitis in both Sub-
Saharan Africa as a region and South Africa as a country. In the 1970’s Freedman described the 
incidence, clinical findings and possible causes of uveitis in South African blacks but very little data 
followed till after the turn of the century.4,5 
 Some recent publications have addressed specific clinical entities as well as diagnostic special 
investigations but epidemiological data from South Africa has remained sparse.6-11  
In 2016 Schaftenaar et al. described their findings in a rural setting in the North-Eastern corner of 
South Africa.12 They reported that 64% of participants in their study were HIV positive (HIV+) and 
that the cause of uveitis was infectious in 72%, idiopathic in 16% and autoimmune in 12%. 
Interestingly, the majority of their infectious cases (51%) was attributed to herpes viruses, followed 
by TB (24%) and Treponema pallidum infection (7%). In this paper we report our findings from a 
tertiary hospital in Cape Town, South Africa which serves a culturally diverse population living in an 
area that differs markedly with regard to climate, geography and socio-economic factors from the 
rural setting described previously. 
Materials and methods 
Study participants and overview of management 
A prospective, cross-sectional study was conducted which enrolled 106 consecutive patients with 
either a first episode of uveitis or pre-existing chronic or relapsing uveitis of unknown cause 
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between February 2014 and July 2015. The patients were all seen and included in the study by a 
single clinician (DPS) at the Eye Clinic of Tygerberg Academic Hospital, a tertiary hospital serving the 
Eastern Metropole of Cape Town as well as the rural West Coast and interior regions of the Western 
Cape Province. Despite being located in a tertiary hospital, most of the patients seen in our Eye Clinic 
were referred from primary level health care practitioners due to the paucity of secondary level eye 
care for patients without medical insurance in our drainage area. To be included in the study, 
patients had to: 1) be 18 years or older, 2) have uveitis of unknown cause and 3) consent to HIV 
testing after appropriate counselling. All participants completed a detailed verbal systemic uveitis 
questionnaire which was followed by a thorough eye examination and a panel of special 
investigations tailored to each patient. The study was approved by the Health Research Ethics 
Committee (HREC) of Stellenbosch University (Ref no N13/10/146) and adhered to the tenets of the 
Declaration of Helsinki. 
Investigations 
a) Baseline 
All participants underwent comprehensive special investigations to search for the underlying cause 
of intraocular inflammation. Blood samples were taken to determine HIV status, CD4+ count if 
indicated, full blood count, erythrocyte sedimentation rate (ESR), rapid plasma reagin (RPR) and 
Treponema pallidum antibodies (TPAbs) for syphilis, creatinine and serum angiotensin converting 
enzyme (sACE) levels. Urine dipstick analysis and chest radiographs were requested in all cases. 
Tuberculin skin tests (TST) and QuantiFERON®-TB Gold (QFT) tests (Cellestis Inc., Chadstone, Victoria, 
Australia) were performed in 89 and 105 participants, respectively. In selected cases, standard or 
high-resolution chest computerized tomography (CT) scans were obtained after consultation with a 
specialist pulmonologist while in some cases positron emission tomography (PET) PET/CT scans were 
requested if considered necessary. An HLA-B27 test was only requested if patients presented with 
severe unilateral fibrinous acute anterior uveitis while anti-Streptolysin O (ASOT) and anti-DNase B 
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titers were only performed in patients under the age of 40 years for possible poststreptococcal 
uveitis(PSU).9  
Second-line 
Anterior chamber (AC) taps were performed as second-line investigations using the method 
described previously.6 Aqueous humor (AH) samples from 100 patients were analysed by 
polymerase chain reaction (PCR) testing for herpes viruses 1 – 6, rubella virus (RV) and Toxoplasma 
gondii (Toxo) by the National Health Laboratory Services Medical Virology laboratory at Tygerberg 
Academic Hospital. Furthermore, paired serum and AH samples from 82 of the participants were 
sent for determination of Goldmann-Witmer coefficients (GWC) for herpes simplex virus (HSV), 
Varicella-Zoster virus (VZV), Cytomegalovirus (CMV), RV and Toxoplasmosis as described previously 
at the department of Medical Microbiology, University Medical Center in Utrecht, The Netherlands.13  
How diagnoses were made 
In this study, intraocular TB (IOTB) was diagnosed as confirmed, probable or possible using the 
proposed classification by Gupta et al.14  Syphilitic uveitis was diagnosed if patients had a compatible 
clinical picture and both a positive TPAbs test as well as a RPR titer ≥ 1:16. Patients with only a 
positive TPAbs test were therefore not diagnosed as having syphilitic uveitis. Poststreptococcal 
uveitis was diagnosed in patients with elevated anti-Streptolysin O and/or anti-DNase but only after 
all other potential causes had been excluded.8 
 Herpetic and rubella-virus associated uveitis was identified in patients with a suggestive clinical 
picture as well as a positive PCR and/or GWC result for the specific virus. All 3 cases of rubella-virus 
associated uveitis had a clinical picture compatible with Fuchs’ uveitis syndrome (FUS). HIV-induced 
uveitis was diagnosed in the presence of a typical clinical picture with the HIV viral load (VL) in the 
eye at least 2 log units higher than the HIV VL in the serum.11 For a diagnosis of Toxoplasma uveitis 
we required a compatible clinical picture with either positive serology or a positive PCR and/or GWC 
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for Toxoplasma. Sarcoidosis and Vogt-Koyanagi-Harada (VKH) disease were diagnosed according to 
the International Workshop on Ocular Sarcoidosis (IWOS) criteria and revised diagnostic criteria for 
VKH disease, respectively.15,16 HLAB27-associated acute anterior uveitis was diagnosed in patients 
with a severe unilateral fibrinous anterior uveitis and a positive HLAB27 blood test while Granuloma 
annulare-associated uveitis was diagnosed when histological findings on a skin biopsy confirmed the 
condition in the absence of any other positive findings.17,18 In those cases where the intraocular 
inflammation could not be attributed to any ocular or systemic disease the uveitis was considered to 
be idiopathic. 
Statistical analysis 
IBM SPSS version 24 (IBM Corp. Released 2016. IBM SPSS Statistics for Windows, Version 24.0. 
Armonk, NY: IBM Corp.) was used to analyse the data, using a significance level of 0.05. Categorical 
factors were compared between groups using Pearson’s chi square test. Continuous variables were 
tested for normality and if plausibly normally distributed, means were compared between more 
than two independent groups using one-way ANOVA tests with Bonferroni adjusted post hoc tests, 
and if not, non-parametric equivalent tests, for instance the Kruskal-Wallis test, were used, with 
Mann Whitney tests to compare relevant two-way associations.  
Results 
Demographics and clinical findings 
A total of 106 consecutive patients with uveitis were enrolled of which 52 (49.1%) were black 
African, 49 (46.2%) of mixed ethnicity, 3 (2.8%) Caucasian and 2 (1.9%) of Asian origin (Table 1). The 
mean age of all participants was 38.6 ± 12.5 years and most were female (n=62; 58.5%). Sixty-six 
participants (62.3%) were HIV negative (HIV-) and 40 (37.7%) HIV+ with a median CD4+ cell count of 
242 x 106/l [interquartile range 99 - 507]. Seventeen of the 40 HIV+ cases (42.5%) were already using 
highly active anti-retroviral therapy (HAART) when they were enrolled in the study while 12 of 40 
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HIV+ cases (30%) were newly diagnosed with HIV infection upon presentation to our Eye clinic. 
Thirty-one of 52 black patients (59.6%) were HIV+ whereas 8 of 49 patients (16.3%) of mixed 
ethnicity were HIV+. In our study population, black African patients were much more frequently 
HIV+ compared to patients of mixed ethnicity (p<0.001).  There was however no meaningful 
difference in median CD4+ cell count between HIV+ patients in the black (338.0) and mixed ethnicity 
(168.5) groups, respectively (p=0.720, Mann-Whitney U test). Bilateral involvement occurred in 47 
cases (44.3%) and unilateral involvement in 59 cases (55.7%). Anatomically, 62 cases (58.5%) had 
anterior uveitis, 34 cases (32.1%) panuveitis and 6 cases (5.7%) posterior uveitis while 4 cases (3.8%) 
presented with intermediate uveitis. Granulomatous uveitis was seen in 45 cases (42.5%).  
At presentation, 48 patients (45.3%) had a decimal Snellen visual acuity (VA) of worse than 6/60 in 
the affected or worse affected eye while 27 patients (25.5%) had a VA between 6/60 – 6/15 and 31 
patients (29.2%) had a VA ≥ 6/12. In patients with infectious uveitis 38 cases (54.3%) had a VA < 
6/60, 17 cases (24.3%) had a VA between 6/60 – 6/15 and 15 cases had a VA ≥ 6/12 while in patients 
with non-infectious uveitis only 2 cases (11.1%) had a VA < 6/60, 7 (38.9%) had a VA between 6/60 – 
6/15 and 9 (50.0%) had a VA ≥ 6/12 (Table 2). Patients with infectious uveitis therefore had poorer 
VA than those with non-infectious uveitis (p=0.014, Pearson Chi-Square test). Twenty-eight of 31 
patients (90.3%) with VA ≥ 6/12 had anterior or intermediate uveitis while only 3 of 31 patients 
(9.7%) with posterior or panuveitis presented with VA ≥ 6/12. In contrast, 27 of 48 patients (56.3%) 
with VA < 6/60 had posterior or panuveitis. Patients with anterior or intermediate uveitis therefore 
were more likely to have VA ≥ 6/12 than patients with posterior or panuveitis (p<0.001, Pearson Chi-
Square test). 
Causes of uveitis 
An infectious cause was identified in 70 cases (66.0%) whereas 18 cases (17.0%) either had a non-
infectious cause or were considered to be idiopathic, respectively (Table 1). In 40 HIV+ patients an 
infectious cause was found in 32 cases (80.0%) while a non-infectious cause was found in only 2 
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cases (5.0%) and 6 cases (15.0%) were idiopathic (p=0.024, Pearson Chi-Square test). In 66 HIV- cases 
an infectious cause was found in 38 cases (57.6%) while a non-infectious cause was identified in 16 
cases (24.2%) and 12 cases (18.2%) were considered to be idiopathic. 
a) Infectious uveitis 
IOTB was the most common infectious cause identified in our study. In total, 35 of 106 cases (33.0%) 
were diagnosed as having probable or possible IOTB representing 35 of 70 (50.0%) of all infectious 
cases (Table 3). Twelve of 35 cases (34.3%) fulfilled the criteria for probable IOTB and 23 of 35 cases 
(65.7%) were labelled as possible IOTB. Eight of the 12 probable IOTB cases (66.6%) and only 3 of the 
23 possible IOTB cases (13.0%) were HIV+.9 The median CD4+ cell count of all HIV+ cases with IOTB 
was 249 x 106/l [interquartile range 70 – 464]. 
Herpetic uveitis accounted for 13 of 106 cases (12.2%) making it the second largest group with VZV 
being responsible for 7 of 13 cases (53.8%), CMV for 5 cases (38.5%) and HSV for 1 case (7.7%) in this 
subgroup. Eight of 13 cases (61.5%) of herpetic uveitis were HIV+ with a median CD4+ cell count of 
94 x 106/l [interquartile range 61 – 449] (Table 4). Syphilis was the third most common cause of 
infectious uveitis with 11 of 106 cases (10.4%) testing positive for the disease. Nine of 11 (81.8%) 
cases with syphilitic uveitis were HIV+ with a median CD4+ cell count of 172 x 106/l [interquartile 
range 138 – 400]. Four cases (3.8%) of Toxoplasma, 3 cases (2.8%) each of rubella virus and PSU as 
well as 1 case of HIV-induced uveitis (0.9%) were responsible for the remainder of the infectious 
cases. Infectious causes were much more common than other causes in HIV+ cases (p=0.024, 
Pearson Chi-Square test). In HIV+ cases with CD4+ cell count <200 x 106/l, 18 of 19 cases (94.7%) had 
an infectious cause while in cases with CD4+ cell count ≥ 200 x 106/l only 14 of 21 cases (66.7%) had 
an infectious cause. Whilst this demonstrated a trend for infectious causes to be more common in 
HIV+ patients with lower CD4+ cell counts it did not reach statistical significance (p=0.079, Pearson 
Chi-Square test). 
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b) Non-infectious uveitis 
Sarcoidosis was diagnosed in 8 of 106 participants (7.5%) all of whom were HIV-. According to the 
IWOS criteria there were 6 cases of presumed ocular sarcoidosis and 1 case each of probable and 
definite ocular sarcoidosis. HLAB27-associated acute anterior uveitis was also diagnosed in 8 of 106 
cases (7.5%) of which 6 (75%) were HIV-. The remaining 2 cases of non-infectious uveitis were 
diagnosed with VKH and Granuloma annulare-associated uveitis, respectively. 
c) Idiopathic uveitis 
In a total of 18 of 106 cases (17.0%) we were not able to identify an underlying ocular or systemic 
cause for the intraocular inflammation. The median CD4+ cell count of HIV+ patients with idiopathic 
uveitis was 489 x 106/l [interquartile range 467 – 716] which is considerably higher than that seen in 
herpetic (94 x 106/l), syphilitic (172 x 106/l) and tuberculous (249 x 106/l) uveitis respectively 
(p=0.002, Mann-Whitney U test). The median CD4+ cell counts of HIV+ patients with different 
underlying diagnoses are summarised in Table 4. Immune recovery uveitis was considered in all 
cases where HAART had been recently initiated but none of the cases warranted such a diagnosis. 
Anatomical distribution of uveitis 
Table 3 shows a summary of all the causes of uveitis stratified by HIV status and anatomical 
distribution. The 3 most common diagnoses in HIV+ patients with anterior uveitis were probable 
IOTB (n=4; 20.0%), syphilis (n=4; 20.0%) and idiopathic (n=4; 20.0%) while in HIV- patients with 
anterior uveitis the 3 most common diagnoses were possible IOTB (n=13; 31.0%), idiopathic (n=9; 
21.4%) and HLA-B27 associated anterior uveitis (n=6; 14.3%).  
The most common diagnoses in HIV+ patients with panuveitis in descending order were syphilis 
(n=4; 26.7%), probable IOTB (n=4; 26.7%) and Toxoplasma as well as VZV (n=2 each; 13.3%) whereas 
in HIV- individuals with panuveitis the most common diagnoses were possible IOTB (n=7; 36.8%), 
presumed ocular sarcoidosis, probable IOTB and idiopathic uveitis (n=3 each; 15.8%).  
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In posterior uveitis, syphilis, Toxoplasma and probable IOTB were diagnosed in the HIV- patients 
while the HIV+ group had diagnoses of CMV, VZV and idiopathic PU. Both HIV- patients with 
intermediate uveitis had presumed ocular sarcoidosis while the 2 HIV+ patients with intermediate 
uveitis had poststreptococcal uveitis and syphilitic uveitis, respectively.  
Interestingly, HIV+ cases were not more prone to having posterior or panuveitis and HIV- cases were 
not more prone to having anterior or intermediate uveitis (p=0.568). HIV+ cases with anterior and 
intermediate uveitis did however have much higher median CD4+ cell counts than those with 
posterior and panuveitis (p=0.006, Kruskal-Wallis test).  
Discussion 
This study provides prospectively collected data about the aetiology of uveitis in patients living in the 
South-western corner of South Africa, an area that is culturally, geographically and socio-
economically diverse. The majority of patients seen at our facility are either black Africans or of 
mixed ethnicity and live under suboptimal socio-economic circumstances. In total, 37.7% of patients 
included in our study had HIV infection which is noticeably lower than the 64% reported from rural 
South Africa.12 Closer inspection however reveals that only 16.3% of mixed ethnicity patients were 
HIV+ compared to 59.6% of black patients. Less than half of the HIV+ patients were receiving HAART 
when they were enrolled in the study for two main reasons. Firstly, the policy of the South African 
National Department of Health at the time when the study was conducted was to only provide anti-
retroviral medication to HIV+ individuals with CD4+ counts < 350 x 106/l. This policy has 
subsequently been amended so that HAART is now available to all patients with newly diagnosed 
HIV infection in South Africa. Secondly, almost 1 in 3 of the HIV+ cases were newly diagnosed with 
HIV infection upon presenting to the Eye clinic which underlines the importance of testing the HIV 
status of patients presenting with uveitis in our area. 
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In the HIV+ group some interesting observations emerged regarding the CD4+ counts. In table 1 we 
indicated that, as expected, patients with infectious uveitis had much lower median CD4+ counts 
than those with non-infectious or idiopathic uveitis. In table 2 we explored the possible association 
between low CD4+ count and poor visual acuity (< 6/60) and although we could not demonstrate 
statistical significance due to the relatively small sample size we still found that half of all HIV+ cases 
had a VA < 6/60 and that this group had a median CD4+ count of well below 200 x 106/l whereas 
cases with better visual acuity had higher CD4+ counts. In table 3 we demonstrated that patients 
with posterior or panuveitis had significantly lower median CD4+ counts than those with anterior or 
intermediate uveitis while in table 4 we highlighted the fact that cases with a high likelihood of an 
actual infection such as probable IOTB, herpetic and syphilitic uveitis had much lower median CD4+ 
counts than idiopathic or possible IOTB cases where the inflammation is more likely to be due to an 
immune-mediated response against unknown antigens. 
Overall, infectious uveitis was far more common than non-infectious and idiopathic uveitis 
respectively but even more so in the HIV+ group compared to the HIV- group. The vast majority of 
uveitis cases were either classified as anterior or panuveitis which is compatible with what has 
previously been reported from elsewhere in Africa.19 Cases with anterior or intermediate uveitis 
were found to have better VA than cases with posterior or panuveitis while cases with infectious 
uveitis were found to have worse VA than cases with non-infectious uveitis. Given the high 
prevalence of both TB and HIV in our area and their known clinical association it is not surprising that 
possible or probable IOTB was the most common cause of infectious uveitis in our study. This once 
again raises the issue about the pathophysiology of IOTB and how much of the clinical picture in any 
given patient should be attributed to direct infection as opposed to an immunological reaction 
against as yet unspecified TB antigens. In an earlier paper we reported that HIV- patients are more 
likely to have possible IOTB and HIV+ patients are more likely to have probable IOTB and here we 
have shown that HIV+ cases with possible IOTB have a higher median CD4+ count than those with 
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probable IOTB.9 It has recently been proposed that TB and sarcoidosis may actually lie on opposite 
ends of the same spectrum of disease.20 
 In keeping with this hypothesis, both possible and probable IOTB would then fit in somewhere 
between pure sarcoidosis and pure TB – most likely in the tuberculous sarcoid (TS) classification – as 
they have clinical and immunological features suggestive of TB and yet a definitive diagnosis of TB 
cannot be made. Herpetic uveitis was the second most common cause of infectious uveitis and, as in 
other reports from Sub-Saharan Africa, VZV was again responsible for more cases than CMV.12,21 
Syphilitic uveitis was the third most common infectious cause and was associated with HIV infection 
in over 80% of cases. This finding lends support to reports from elsewhere in the world that syphilis 
is still an important cause of uveitis, especially in HIV+ patients, and should be actively searched for 
in the workup of any patient with uveitis.3 Other infectious causes identified included Toxoplasma 
and rubella virus even though neither of these infections were diagnosed in the rural setting. This 
may reflect regional differences in pathogens.  
In patients with non-infectious uveitis, sarcoidosis and HLA-B27 associated AU were the most 
common causes and most patients were HIV-. Idiopathic uveitis was twice as prevalent in HIV- 
patients while HIV+ patients with idiopathic uveitis had significantly higher median CD4+ cell counts 
than those with ocular infections. This would appear to suggest that immunocompromised patients 
with lower CD4+ cell counts are less likely to have a final diagnosis of idiopathic uveitis. 
A potential limitation of our study is that it was conducted at a tertiary hospital instead of a primary 
healthcare facility which may introduce selection bias due to the high likelihood that not all cases of 
uveitis would have been referred to our facility. Another limitation of our study is that patient 
follow-up was often erratic due to socio-economic challenges and that in certain cases the response 
to empiric treatment could not be monitored, definitive diagnoses could not be communicated to 
patients or imaging studies could not be performed. A potential strength of this study is that it 
provided patients with access to investigations such as QuantiFERON®, GWC and PET/CT that would 
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previously have been inaccessible due to financial constraints and logistical problems. It also 
afforded the investigators the opportunity to assess the value of these investigations in the South 
African context. 
Conclusion 
Uveitis is a multi-faceted clinical entity that often requires a considerable amount of effort to allow 
the correct diagnosis to be made. Despite ongoing advances in diagnostic modalities, a definitive 
diagnosis can still not be made in a significant proportion of patients. In developing countries such as 
South Africa where HIV, TB and syphilis are highly prevalent an infectious cause may be found in up 
to two-thirds of cases and must therefore be sought in earnest since properly targeted treatment 
may significantly reduce the burden of this potentially blinding entity on society. 
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Table 1: Demographic and clinical data stratified by infectious, non-infectious and 
idiopathic uveitis 
 
Characteristics All participants 
(n=106) 
Infectious 
(n=70) 
Non-
infectious 
(n= 18) 
Idiopathic 
(n=18) 
p-value 
      
Age, years (±SD) 38.6 (12.5) 39.0 (11.8) 38.2 (13.1) 37.7 (15.0) 0.919 
      
Gender (%)     0.736 
Male 44 (41.5) 30 (42.9) 6 (33.3) 8 (44.4)  
Female 62 (58.5) 40 (57.1) 12 (66.7) 10 (55.6)  
      
Ethnicity (%)     0.232* 
Black 52 (49.1) 38 (54.3) 6 (33.3) 8 (44.4)  
Mixed 49 (38.9) 30 (42.9) 12 (66.7) 7 (38.9)  
White 3 (2.8) 1 (1.4) 0 (0) 2 (11.1)  
Asian 2 (1.9) 1 (1.4) 0 (0) 1 (5.6)  
      
Laterality (%)     0.55 
Unilateral 59 (55.7) 40 (57.1) 11 (61.1) 8 (44.4)  
Bilateral 47 (44.3) 30 (42.9) 7 (38.9) 10 (55.6)  
      
Anatomic distribution 
(%) 
    0.276 
Anterior 62 (58.5) 37 (52.9) 12 (66.7) 13 (72.2)  
Intermediate 4 (3.8) 2 (2.9) 2 (11.1) 0 (0)  
Posterior 6 (5.7) 5 (7.1) 0 (0) 1 (5.6)  
Panuveitis 34 (32.1) 26 (37.1) 4 (22.2) 4 (22.2)  
      
Appearance (%)     0.395 
Granulomatous 45 (42.5) 33 (47.1) 6 (33.3) 6 (33.3)  
Non-granulomatous 61 (57.5) 37 (52.9) 12 (66.7) 12 (66.7)  
      
Snellen VA (%)     0.014 
≥ 6/12 31 (29.2) 15 (21.4) 9 (50.0) 7 (38.9)  
6/60 - 6/15 27  (25.5) 17 (24.3) 7 (38.9) 3 (16.7)  
<6/60 48 (45.3) 38 (54.3) 2 (11.1) 8 (44.4)  
      
HIV-status (%)     0.024 
Negative 66 (62.3) 38 (54.3) 16 (88.9) 12 (66.7)  
Positive 40 (37.7) 32 (45.7) 2 (11.1) 6 (33.3)  
Median CD4 [IQR] 242 [99 - 507] 172 [87 -415] 719 [552 - 
886] 
486 [467 - 
716] 
0.04** 
      
Abbreviations: SD = standard deviation; IQR = interquartile range; VA = 
visual acuity 
  
*p-value represents comparison between black and mixed 
ethnicity groups 
   
** p-value represents comparison between infectious and non-infectious as well as  
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infectious and idiopathic 
 
 
 
 
 
Table 2: Visual acuity according to anatomical distribution, type of uveitis and HIV 
status 
 
  Snellen BCVA    
 Total 
cases 
VA <6/60 
(n=48) 
VA 6/60 - 6/15 
(n=27) 
VA ≥6/12 
(n=31) 
p-
value 
      
Anatomical distribution     <0.001 
Anterior uveitis 62 20 (41.7) 15 (55.6) 27 (87.1)  
Panuveitis 34 24 ( 50.0) 7 (25.9) 3 (9.7)  
Posterior uveitis 6 3  (6.3) 3 (11.1) 0  
Intermediate uveitis 4 1 (2.0) 2 (7.4) 1 (3.2)  
      
Type of uveitis     0.014 
Infectious 70 38 (79.2) 17 (63.0) 15 (48.4)  
Non-infectious 18 2 (4.2) 7 (25.9) 9 (29.0)  
Idiopathic 18 8 (16.7) 3 (11.1) 7 (22.6)  
      
HIV status     0.699 
Negative 66 28 (58.3) 17 (63.0) 21 (67.7)   
Positive 40 20 (41.7) 10 (37.0) 10 (32.3)  
Median CD4 count if 
HIV+ [IQR] 
242 [99 - 
507] 
172 [86 - 486]  298 [88 - 467] 484 [121 - 
863] 
0.218 
      
BCVA = best corrected visual acuity     
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Chapter 10: Original article – NOT YET SUBMITTED FOR PUBLICATION 
Ocular syphilis and neurosyphilis in HIV positive and HIV negative patients: Can immunoblotting 
shed new light?  
Introduction 
Syphilis is a sexually transmitted infection caused by the spirochete Treponema pallidum. The clinical 
manifestations of systemic syphilis are typically divided into 4 stages: primary, secondary, latent and 
tertiary although ocular involvement may occur in any of these stages.1 Syphilis was an important 
cause of uveitis in the first half of the twentieth century but after the introduction of penicillin the 
prevalence dropped considerably. However, during the first decade of the twenty-first century there 
has been a resurgence with an increasing number of cases being reported by several authors.2-5 
 The majority of these cases were reported in males, especially those between 20 - 30 years of age, 
many of whom exhibited high-risk sexual behaviour.6 The association between syphilis and HIV 
infection has also been well described and all HIV-infected patients with uveitis should be 
investigated for syphilis and vice versa.7 Furthermore, it has been reported that the association 
between uveitis and neurosyphilis is greater in HIV+ patients than in immunocompetent patients 
and that cerebrospinal fluid (CSF) analysis should therefore be performed in all HIV+ patients with 
syphilitic uveitis.1  
During the secondary and tertiary stages of the disease, uveitis is the most common ocular 
manifestation of syphilis.8 Embryologically, the optic nerve and retina develop as extensions of the 
brain and many authors contend that syphilitic retinitis and optic neuritis represent a form of 
neurosyphilis and should therefore be treated as such.3,9,10 Whether syphilitic anterior uveitis should 
be considered in the same light is the subject of an ongoing debate. Many experts suggest that all 
cases of ocular syphilis should be considered identical to neurosyphilis while others are not yet 
convinced.11  
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The diagnosis of ocular syphilis is made, after exclusion of other possible causes, if a patient has 
ocular inflammation compatible with syphilis and positive syphilis serology which should include 
both a treponemal and a non-treponemal test. The Centres for Disease Control (CDC) recommend a 
treponemal test such as an enzyme immunoassay (EIA) which detects antibodies to treponemal 
antigens as an initial screening test for syphilis.4 If positive, this should be followed by a non-
treponemal test such as the Venereal Disease Research Laboratory (VDRL) or the rapid plasma reagin 
(RPR) which detects antibodies directed against membrane phospholipids such as cardiolipin. These 
tests are used to screen for active disease and to quantify antibodies but may give false positive 
results in diseases other than syphilis such as collagen vascular diseases.8 Specimens with discordant 
results (i.e. EIA positive and RPR negative) should be submitted for a confirmatory test such as 
treponema pallidum particle agglutination test (TP-PA) as a diagnosis of syphilis is confirmed if the 
latter test is positive. Treponemal test reversion may occur in 5 – 17% of patients who were treated 
for early syphilis. This contradicts the dogma that these tests always remain positive after infection 
by T pallidum, which is in fact a misconception.8  
According to the CDC, confirmed neurosyphilis is diagnosed when VDRL testing is positive on 
cerebrospinal fluid (CSF) and probable neurosyphilis is diagnosed when CSF VDRL is negative but CSF 
protein and/or white cell count is elevated in the presence of clinical signs or symptoms which may 
include ocular findings.12,13 However, CSF abnormalities such as higher mean white cell counts and 
protein levels are common in HIV-infected patients, even in the absence of syphilis. Diagnosing 
probable neurosyphilis in HIV-infected patients may therefore be problematic although recently 
published algorithms on diagnosing neurosyphilis, in HIV+ and HIV- patients respectively, are proving 
helpful.14 
The advent of techniques such as PCR has brought about interesting new diagnostic possibilities in 
both ocular syphilis and neurosyphilis. PCR has been used to detect the presence of treponemal DNA 
in both aqueous and vitreous humor from eyes with suspected ocular syphilis, thus confirming the 
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diagnosis.10,15-17 It has also been used to detect treponemal DNA in CSF from patients with 
neurosyphilis.18 However, further investigation is required to determine whether performing PCR on 
both intraocular fluid and CSF from patients with suspected ocular syphilis and neurosyphilis will 
enable us to develop a better understanding of how these two conditions relate to one another. 
Immunoblotting is another technique that is able to confirm the diagnosis of syphilis by detecting 
antibodies to specific treponemal antigens. In a study that compared a Western blot to the FTA-ABS 
as a confirmatory test for syphilis both tests had sensitivities of 100% while the specificities were 
100% and 94.5% for the Western blot and FTA-ABS, respectively.19 In another study, the Western 
blot had 93.8% sensitivity and 100% specificity compared to the 91.7% sensitivity and 92.0% 
specificity of the FTA-ABS.20 Immunoblotting has previously been used to detect antibodies against T 
pallidum antigens in the CSF of patients with neurosyphilis21 but there are no reports in the 
literature of it having been used for the detection of treponemal antibodies in aqueous or vitreous 
humor. The use of PCR to detect treponemal DNA and immunoblotting to detect antibodies against 
T pallidum22 in the CSF and aqueous humor of patients suspected of having ocular syphilis and 
neurosyphilis could potentially improve diagnostic accuracy and increase our insight into how these 
conditions relate to each other. 
Materials and methods 
Study participants 
Between February 2014 and July 2015 we enrolled 106 consecutive patients in a prospective, cross-
sectional study who had either a first episode of uveitis or pre-existing chronic or relapsing uveitis of 
unknown cause. All patients were seen and included in the study by a single clinician (DPS) at the Eye 
Clinic of Tygerberg Academic Hospital on the outskirts of Cape Town. Inclusion criteria were: 1) age 
18 years or older, 2) uveitis of unknown cause and 3) consent for HIV testing after appropriate 
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counselling. The study was approved by the Health Research Ethics Committee (HREC) of 
Stellenbosch University (Ref N13/10/146) and adhered to the tenets of the Declaration of Helsinki. 
Investigations 
a) Baseline 
All participants underwent comprehensive special investigations to look for the underlying cause of 
the intraocular inflammation as described previously.23,24 Specifically, blood samples were taken to 
determine HIV status, and CD4+ count if indicated, as well as an EIA for Treponema pallidum 
antibodies (TPAbs) and RPR. Due to financial constraints we were not able to perform a confirmatory 
TP-PA test in patients with discordant results but patients with TPAbs+ RPR- results were included 
for further investigation as outlined below.  
b)  Second-line 
If participants were found to have a positive serum RPR and/or TPAbs result they were investigated 
further to search for evidence of ocular and/or neurosyphilis (Figure 1). An aqueous humor (AH) 
sample was collected from all patients with positive serology, as previously described,25 for syphilis 
PCR testing as well as a syphilis immunoblot. If either the syphilis PCR or immunoblot were positive 
the patient was considered to have confirmed ocular syphilis. If both tests were negative and no 
alternative, plausible underlying cause of uveitis was identified the patient was considered to have 
probable ocular syphilis. However, given the high prevalence of syphilis in developing countries and 
the high likelihood of previous or partial treatment of syphilis we only made a final diagnosis of 
ocular syphilis if the RPR titer was ≥ 1:16 in an attempt to exclude false positive cases. 
Lumbar punctures were also performed to collect CSF samples to test for VDRL, FTA-ABS, syphilis 
PCR, syphilis immunoblot, CSF protein and CSF leukocytes. If any of the VDRL, syphilis PCR or syphilis 
immunoblot were positive the patient was considered to have confirmed neurosyphilis. If all 3 were 
negative but CSF proteins or leukocytes were raised a diagnosis of probable neurosyphilis was made 
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in HIV- patients whereas if all 3 were negative but CSF leukocytes were raised or CSF FTA-ABS was 
positive then probable neurosyphilis was diagnosed in HIV+ patients according to the most recent 
guidelines.13 
c) Details of novel laboratory techniques and their interpretation – PCR  and immunoblot  
PCR analysis was performed essentially as described previously with minor modification.26 Nucleic 
acids was extracted from 12.5 l of ocular fluid and 250 l of cerebrospinal fluid, respectively, using 
the MagnaPure 96 DNA and Viral NA LV extraction kit (Roche, Mannheim, Germany). Each samples 
was spiked with a fixed amount of Phocid herpes virus type 1 to monitor the extraction and 
amplification process. Samples were eluted in 100 l of elution buffer of which 10 l was used per 
amplification. Real-time PCR was performed on an ABI Taqman Fast 7500 (ABI, Foster City, CA, USA). 
Treponema pallidum-specific primers and probe were as described by Koek et al.; forward primer 
5’GGT AGA AGG GAG GGC TAG TA 3’, reverse primer 5’CTA AGA TCT CTA TTT TCT ATA GGT ATG G 3’, 
probe 5’ FAM-ACA CAG CAC TCG TCT TCA ACT CC-TAMRA 3’.27 
Immunoblotting was performed using the INNO-LIATM Syphilis Score (Fujirebio, Gent, Belgium) 
according to the instructions of the manufacturer. Samples were tested at a 1:100 dilution unless 
indicated otherwise.  Determination of intraocular or intrathecal antibody production against 
treponemal proteins TpN47, TpN17, TpN15 and TmpA was done by visual assessment in the first 
instance (Figure 2). Reversed intensity of bands between ocular fluid and CSF versus serum was 
considered indicative for local antibody production. In addition, the intensity of the blot bands were 
quantitated in order to calculate a Goldmann-Witmer coefficient (GWC) for local antibody 
production. To this end, the immunoblot strips were scanned in the bio-imaging analyzer LAS 4000. 
The intensity of the individual antigen bands was quantified using the 1D gel analysis module of the 
ImageQuant TL software (IQTL version 8.1; GE Healthcare, Little Chalfont, UK). Measurement lanes 
were drawn manually across each scanned strip and the intensity of the bands was calculated 
automatically by the IQTL software. Band intensities were adjusted to the background and 
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normalized to the intensity of the +/- control band present on each strip, where the control band 
was set at 100%. Each strip was measured three times and the mean intensity was used for further 
calculation of the GWC for each TP antigen band. Prior to GWC calculation the measured band 
intensities were corrected for the dilution used. The GWC was calculated as follows: [mean intensity 
TP antigen OF or CSF/total IgG OF or CSF]/[mean intensity TP antigen serum/total IgG serum] were a 
value over 3 was considered positive. 
Results for CSF and AH were summarised after both visual assessments and LAS/GWC calculations 
had been completed. Overall results were considered positive if in a specific sample both the visual 
assessment and at least one band of the LAS/GWC were positive. If visual assessment was negative a 
LAS/GWC result was considered positive when at least 2 bands on the strip registered positive result. 
Overall results were considered indeterminate when either the visual assessment or the LAS/GWC 
result was positive for a specific sample and a negative result was recorded if both the visual 
assessment and the LAS/GWC results were negative.  
Results 
Demographics and clinical findings of all TPAbs positive cases 
In total, 21 of 106 cases tested positive for TPAbs by EIA. The mean age of this subgroup of patients 
was 42.6 ± 12.8 years and the male to female ratio was 1:2. Eleven patients were black Africans, 9 
were of mixed ethnicity and 1 Caucasian. Bilateral involvement occurred in 10 cases and only 8 had a 
granulomatous appearance clinically. Twelve patients had anterior uveitis, 1 intermediate, 2 
posterior and 6 panuveitis. 
Routine serum tests 
Of the 21 patients who tested positive for TPAbs by EIA, only 14 also had a positive RPR result with 
titers ranging from 1:1 to 1:512. Syphilis immunoblot tests that were carried out at a later stage at 
the University Medical Center in Utrecht, The Netherlands, revealed that 15 samples had positive 
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immunoblot results, 2 had indeterminate results and 1 was negative. Three samples were not tested 
by immunoblot. Furthermore, 15 of the 21 participants with positive TPAbs results were also HIV+ 
with a median CD4+ cell count of 181 x 106/L (Table 1). 
Routine CSF tests 
VDRL was positive in 3 cases, negative in 15 cases and not done in 3 cases. FTA-ABS was positive in 6 
cases, equivocal in 2 cases and negative in 13 cases. All 3 cases that did not have a VDRL test had 
negative FTA-ABS test results which effectively ruled out a diagnosis of neurosyphilis. CSF protein 
levels and total white cell counts are also shown in Table 1. According to these results, 4 cases meet 
the CDC criteria for neurosyphilis as 3 cases have a reactive VDRL test on CSF (confirmed 
neurosyphilis) and the other has a positive FTA-ABS test as well as raised CSF white cell count 
(probable neurosyphilis). However, according to the UpToDate algorithms by Marra, 2 additional 
patients would have required treatment for probable neurosyphilis.13 Both of these cases were HIV- 
and had negative results for both VDRL and FTA-ABS on CSF but one had significantly raised CSF 
protein levels and the other  a raised CSF white cell count. 
Additional CSF tests 
The PCR and immunoblot results, including the GWC results for each antigen band, are given in Table 
2. Five cases tested positive for treponemal proteins on CSF by immunoblot and it should be noted 
that 2 cases with neurosyphilis, 1 confirmed and 1 probable according to the CDC criteria, were not 
tested by immunoblot due to insufficient sample availability. Furthermore, 9 cases tested negative, 2 
results were indeterminate and 5 cases in total were not tested. Of the five immunoblot CSF-positive 
cases, the first (Patient 2) would have been diagnosed as having probable neurosyphilis according to 
the CDC criteria based on a positive CSF FTA-ABS result and raised white cell count. The second 
positive case (Patient 11) did not have neurosyphilis according to either the CDC criteria or the 
UpToDate algorithms but had an equivocal FTA-ABS result and a lymphocyte count of 18/µL  in the 
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CSF i.e. 2 more would have resulted in a diagnosis of probable neurosyphilis. The third immunoblot 
positive case (Patient 50) would have had probable neurosyphilis based on raised CSF protein while 
the fourth (Patient 52) would have been diagnosed as having probable neurosyphilis had the CSF 
white cell count been 6 instead of 5. The fifth case (Patient 85) was CSF VDRL- FTA-ABS + but did not 
fulfil the criteria for probable neurosyphilis based on a normal CSF white cell count. All cases were 
negative by syphilis PCR on CSF.  
Additional aqueous humor tests 
The PCR and immunoblot results, including the GWC results for each antigen band, are given in Table 
2. Three cases tested positive for treponemal proteins by immunoblot and it should be noted that 5 
cases with probable ocular syphilis were not tested by immunoblot for various reasons although 
some samples are due to be tested in the near future (Table 2). Eight cases tested negative and 8 
cases in total were not tested. Also, in 2 cases the results were considered to be indeterminate when 
there were conflicting outcomes between the visual evaluation and the actual immunoblot results. 
The first 2 cases with positive AH immunoblot results also had positive CSF immunoblot results while 
the third case had a negative blot result for CSF even though the CSF VDRL test was reactive with a 
titer of 1:4. All cases tested negative for syphilis PCR on AH. 
Summary 
After reviewing all the available data for each patient, and then applying our proposed classification, 
we arrived at a final diagnosis as depicted in Table 2.  
Discussion 
The relationship between ocular syphilis and neurosyphilis is poorly understood and a lot of our 
current understanding is based on assumption rather than scientific fact. The first of these 
assumptions is that ocular syphilis may be accurately diagnosed based on positive blood serology, 
preferably consisting of a positive treponemal and non-treponemal test. While this holds true in 
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most cases of systemic syphilis it is not necessarily true in ocular syphilis. We would therefore like to 
propose that ocular syphilis also be classified into confirmed ocular syphilis and probable ocular 
syphilis in a similar fashion to neurosyphilis. Previously such an approach would not have been viable 
but as molecular diagnostic techniques are constantly evolving and sampling of intraocular fluid has 
become common practice it has now become feasible. It is our contention that a diagnosis of 
confirmed ocular syphilis would require molecular diagnostic evidence in the form of either a 
positive syphilis PCR on ocular fluid or at least evidence of intraocular antibody production against 
known treponemal antigens.10,15,17 On the other hand, a diagnosis of probable ocular syphilis would 
require positive blood serology and the exclusion of other possible causes of ocular inflammation. 
Given the protean manifestations of ocular syphilis we would not include a suggestive clinical 
presentation as a diagnostic criterion.  
Another of these assumptions is that ocular syphilis is a form of neurosyphilis because the eye is 
effectively, or at least embryologically, part of the brain. This paper describes 3 cases where 
immunoblotting of both the AH and CSF of the same patient has delivered positive results which, in 
our opinion, proves that these patients had both ocular and neurosyphilis However, 4 other cases 
were diagnosed as having probable ocular syphilis without any evidence of neurosyphilis and an 
additional 5 cases were diagnosed as having probable ocular syphilis and confirmed neurosyphilis 
according to our proposed classification. Of the 21 patients with positive serum TPAbs tests, only 12 
were eventually diagnosed with ocular syphilis and treated with intravenous penicillin. Based on our 
proposed classification, 3 of these cases could be classified as confirmed ocular syphilis based on 
positive immunoblot results and the remaining 9 as probable ocular syphilis. In one additional case, 
Patient 65, it was uncertain whether there was enough evidence to diagnose ocular syphilis based 
on a positive TPAbs and serum RPR titer of 1:2. Interestingly enough, this patient did not have 
neurosyphilis according to the CDC criteria but did require treatment for neurosyphilis according to 
Marra’s algorithms as she was HIV- and had a CSF lymphocyte count of >5/µL. Unfortunately there 
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was insufficient CSF and AH samples to perform immunoblotting in this case as it may have provided 
some much needed answers. 
To us, it was interesting to note how immunoblotting could potentially improve the accuracy with 
which neurosyphilis is diagnosed. For example, in Patient 11, who was HIV+ with a CD4+ count of 
234 x 106/L, neurosyphilis could not be diagnosed according to the CDC criteria and according to the 
UpToDate algorithms the patient also did not require treatment for neurosyphilis because the CSF 
lymphocyte count was 18/µL instead of the 20 required. However, one should bear in mind that 
these cut-off values are arbitrary and that in a borderline case such as this a positive immunoblot 
result provides supplementary evidence that the patient does indeed require treatment for 
neurosyphilis. In another case, Patient 52, neurosyphilis could not be diagnosed according to the 
CDC criteria and the patient would only have required treatment for neurosyphilis according to 
Marra’s algorithms had the CSF lymphocyte count been >5/µL instead of exactly 5. Once again, the 
positive immunoblot result probably provides enough additional evidence to show that this patient 
requires treatment for neurosyphilis. 
Given the previous papers reporting the use of PCR as a diagnostic tool for ocular syphilis it was 
disappointing to not find a single positive PCR result on either CSF or AH in this study. This may be 
partly to blame on the fact that AH was exclusively sampled and higher yield could possibly have 
been achieved if vitreous humor had been sampled instead. It may, however, also indicate that 
providing evidence of intraocular antibody production against treponemal proteins could possibly be 
a more sensitive diagnostic tool in certain settings although future research would be required to 
confirm or disprove this theory. 
This study has certain limitations in that the sample sizes are quite small and that the authors were 
unable to test all the samples that they ideally would have liked to. However, on the positive side, 
this study is the first to describe the use of immunoblotting on CSF and AH in an attempt to better 
understand the relationship between ocular and neurosyphilis. Also, when considering the final 
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diagnoses in Table 2 it is worthwhile noting that no false positive results were recorded with the 
immunoblot. A much larger study will however be needed to accurately determine the sensitivity 
and specificity of this technique in diagnosing both ocular and neurosyphilis. 
Conclusion 
Given the availability of modern diagnostic techniques, the time has likely come to begin 
distinguishing between confirmed and probable ocular syphilis. Immunoblotting of CSF and AH 
samples of patients with positive blood syphilis serology may provide additional information to aid 
the diagnosis of both ocular and neurosyphilis especially in cases where other results are equivocal. 
 
Figure 1: Algorithm to diagnose ocular syphilis and neurosyphilis
Serum RPR &/or TPAbs 
positive
AH: Syphilis PCR 
: Syphilis Western
Blot
CSF: VDRL
: Syphilis PCR
: Syphilis Western Blot
Positive Negative
Ocular 
syphilis 
No other cause 
of uveitis found
Positive Negative
CSF: FTA-ABS
: Protein
: White cells
Neurosyphilis
Confirmed
Probable Positive Negative
Not neurosyphilisContinue search for other 
cause of uveitis
Confirmed
Probable
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Figure 2: Scanned images of immunoblot strips from two patients with clear differences in their 
pattern profiles. Above the patient number is shown. On the left the four Treponema pallidum 
antigens present on the immunoblot strips are indicated. Below the patient material is given. The 
immunoblot of patient 2 (left hand side) shows a difference in band intensity between the 
cerebrospinal fluid and aqueous humor on the one hand and serum on the other. Clearly, the 
intensity of band TpN17 is higher in CSF and AH than in serum compared to the other bands in the 
same material. The immunoblot of patient 52 (right hand side) shows a difference in intensity 
between CSF and serum, where in the serum the intensity of all band is similar, whereas in CSF the 
TpN17 band is more intense and the TmpA band is less intense than the other two.  
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Chapter 11: Conclusion 
Introduction 
Very little data were available regarding the epidemiology of uveitis in South Africa prior to when 
this research project was undertaken. From conception to the final stages of this project more than 
four years passed and, as alluded to earlier, very few other publications have focused on this 
important topic over that period of time. During the conceptualization of this study the investigators 
therefore were, in a sense, both presented with and confronted by a blank canvas. The main 
challenge was to determine which questions needed to be prioritised and which ones could either 
wait or be referred to other researchers to be answered in the meantime. In the end it was decided 
that the overall epidemiology of intraocular inflammation in our area needed to be investigated as 
no such data existed and that, while doing so, we would pay close attention to the diagnosis of 
specific uveitis entities. 
The pilot study for this project assessed the utility of multiplex PCR in the diagnosis of herpetic 
uveitis (Appendix A).1 Not only was a 47.2% positive PCR yield recorded but it also described a 
significant correlation between being HIV+ and: 1) having a positive PCR yield, 2) having a positive 
EBV PCR result and 3) having a positive CMV PCR result. Furthermore patients with posterior uveitis 
and symptom duration <30 days were also more likely to have a positive PCR yield. These results 
enabled us to make a definitive diagnosis of herpetic uveitis in many cases where this would not 
previously have been possible.  These findings also presented new questions. One specific question 
that kept recurring was how to interpret the finding of a positive EBV PCR result in our setting? It 
was therefore decided to examine this matter more closely. 
Considering that South Africa has the highest prevalence of both TB and HIV infection in the world, 
and that the local patient profile provided a unique setting in which to study this, it was decided to 
focus a lot of attention on these two disease entities.  Firstly, it needed to be established what the 
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prevalence of IOTB in the study area was and whether HIV infection had any effect on this. To realise 
this a collaboration was entered into with the Division of Molecular Biology and Human Genetics and 
specifically the DST/NRF Centre for Excellence in Biomedical TB Research (CBTBR), which is one of 
the Centres of Excellence for research in South Africa, as it provided access to the QuantiFERON TB-
Gold test (QFT) that was not yet available in our clinical setting. Secondly, it needed to be 
determined whether the QFT was indeed superior to a tuberculin skin test (TST) given the highly 
endemic environment for both TB and HIV infection. Lastly, it presented an opportunity to evaluate 
a newly proposed revised international classification system of IOTB and, in so doing, identify areas 
for possible future improvement in this system. 
The pilot study showed that herpes viruses were common causes of uveitis in our environment and 
that viral causes of infectious uveitis also needed to be studied. However, based on publications 
from the Netherlands and Thailand,2-10 it was realised that both rubella virus and HIV per se needed 
to be studied as well. The literature suggested that PCR alone would miss the diagnosis of viral 
uveitis in a significant proportion of cases and that Goldmann-Witmer coefficient calculation could 
improve diagnostic accuracy significantly but the challenge was that GWC testing was not available 
anywhere in South Africa. A decision was made to approach researchers at the University Medical 
Center in Utrecht, The Netherlands, where most of the publications had emanated from, and a 
collaboration agreement was entered into, thereby providing access to diagnostic techniques that 
had never been evaluated in the Southern African setting. 
As the study progressed, collaborative research assisted us to gain access to diagnostic imaging 
modalities, previously thought to be out of our reach. Most importantly, positron emission 
tomography with computed tomography (PET/CT) became available to assist in an attempt to 
differentiate between pulmonary TB and sarcoidosis in uveitis patients. Those results were not 
included in this dissertation but will form a Master of Medicine dissertation for a registrar in Nuclear 
Medicine. An opportunity presented itself to re-evaluate the role of some older modalities, such as 
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chest radiography, in diagnosing the underlying causes of uveitis and a research paper presenting 
those findings will be submitted for publication in the near future by other members of the 
investigating team. 
Another publication that had its origin in this study looked at the ocular and CSF penetration of anti-
retroviral agents (ARV’s) (Appendix B).11 The initial reports on HIV-induced uveitis indicated that the 
condition was not responsive to corticosteroid treatment but responded dramatically to anti-
retroviral agents. A literature search however revealed that very little was known about especially 
the ocular penetration of ARV’s and it was decided to investigate this further. There is no doubt that 
further research needs to be conducted to better understand which ARV’s achieve therapeutic levels 
in the eye. Given an increased awareness of the association between HIV infection and ocular 
inflammation we also described two new forms of immune recovery-based ocular inflammation 
during the course of this project. One paper described an immune recovery response to 
Cryptococcus neoformans (Appendix C) and the other the development of Mooren’s corneal 
ulceration (Appendix D) after immune reconstitution.12,13 
Apart from the aims and objectives defined at the outset we were therefore also able to address 
some additional questions and describe novel findings, thereby increasing the total impact of the 
study.  
Critical appraisal 
Chapter 3 
This chapter presented the first ever report on the prevalence of intraocular tuberculosis in the 
Western Cape Province of South Africa using a revised classification system. Given the high 
prevalence of both TB and HIV in this setting it was not surprising to find that 1 in 3 patients with 
uveitis could be classified as having IOTB. The revised classification was not only found to be more 
useful than previous versions but certain shortcomings were identified that would need to be 
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addressed in future versions of the classification system. The addition of the category called possible 
IOTB was particularly useful as it allowed many patients, who would previously have been labelled as 
having idiopathic uveitis, to be diagnosed with IOTB. This is also the main reason why the reported 
prevalence is almost double that reported by Schaftenaar et al as all the cases of IOTB they 
diagnosed would be classified as probable IOTB.14 It is likely that a significant proportion of the 
patients in their idiopathic group could have been diagnosed as having possible IOTB had they used 
the revised classification by Gupta et al.15 As a result of this research our clinical index of suspicion 
for a diagnosis of IOTB has increased significantly and ophthalmologists are therefore much less 
likely than before to miss a diagnosis of IOTB. 
Chapter 4 
After utilising the revised IOTB classification in this study, Chapter 4 provides novel perspectives 
gained. Four main shortcomings were identified that would need to be addressed in order to further 
improve the accuracy of the classification. In short, given the protean manifestations of ocular TB, it 
was recommended that the number of clinical signs contained in the classification be increased in 
order for more manifestations to be compatible with a diagnosis of IOTB and that it should make 
provision for unusual manifestations of IOTB in immunocompromised patients. Furthermore, a CD4+ 
count of 100 x 106/L was identified to be an arbitrary cut-off value under which both QFT and TST 
results often become falsely negative. In those cases a positive QFT and/or TST result should not be 
mandatory in order to diagnose IOTB provided the rest of the criteria are met. Lastly, based on the 
extensive clinical experience gained in treating patients in the Western Cape, it was recommended 
that a positive 8 week trial of anti-TB treatment should still form part of the diagnostic criteria as we 
often rely on this to guide our decision making in clinical practice in the absence of a gold standard 
for the diagnosis of IOTB. 
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Chapter 5 
Chapter 5 evaluated the utility of QFT and TST as diagnostic tests for IOTB in HIV+ and HIV- patients. 
For many years it was taught that there was no reason to use the TST in adults as they would all 
invariably be positive in a TB endemic area like the Western Cape Province of South Africa. We were 
therefore very excited when the first data regarding the use of QFT to diagnose IOTB was published 
and we hoped that it would improve our ability to accurately diagnose IOTB. However, once the data 
from this study had been analysed, it was concluded that QFT was not superior to TST in our highly 
endemic environment and that it therefore did not warrant the much higher cost involved in a 
limited resource setting. When a comparison was drawn between two countries with a high 
incidence of TB (South Africa and India) and 3 countries with a much lower incidence (Singapore, 
Korea and Spain) the conclusion was that the TST performs better in high incidence countries while 
QFT is more accurate in countries with a much lower incidence of TB. In practice, the number that 
has the most clinical significance is the negative predictive value of 92.1% of the TST as it means that 
a patient with a negative TST only has an 8% chance of still having IOTB. However, it has also been 
noted that in patients with a CD4+ count <100 x 106/L clinicians should be aware of the fact that the 
TST may be false negative.  
Chapter 6 
In Chapter 6 molecular methods were utilised to study the role of Epstein-Barr virus in uveitis as 
there was limited evidence in the literature to prove that the virus actually causes intraocular 
inflammation.  How to interpret a positive result for EBV in a clinical setting was therefore 
questioned. Using both quantitative PCR and GWC no evidence of active intraocular replication or 
antibody production could be found. Furthermore, an alternative, more plausible cause of uveitis 
was identified in the majority of cases that had a positive multiplex PCR result for EBV. The 
recommendation therefore is that EBV should not be considered the sole cause of uveitis unless one 
can demonstrate either intraocular replication and/or intraocular antibody production. 
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Chapter 7 
Chapter 7 reported a case of HIV-induced uveitis who, in contrast to the patients with positive EBV 
multiplex PCR results, had an intraocular HIV viral load more than 150 times higher than in the 
peripheral blood and therefore had evidence of intraocular viral replication. It also described a 
previously unreported finding of small fluffy nodules along the pupil margin which was present in 
photos of previous cases but not highlighted at the time. This case was published in the journal 
‘AIDS’ in order to increase awareness of this highly treatable form of uveitis amongst all healthcare 
practitioners who work with people living with HIV infection. 
Chapter 8 
Chapter 8 describes the findings regarding the use of both PCR and GWC testing to diagnose 
infectious uveitis in HIV+ and HIV- patients and 3 main differences between these 2 groups were 
identified. Firstly, HIV+ patients were more likely to have positive PCR results than GWC results. The 
interpretation of this finding is that HIV+ patients, especially those with lower CD4+ counts, are 
more prone to having actual intraocular infections and the likelihood of finding a pathogen’s DNA or 
RNA in ocular fluid is therefore higher. Secondly, HIV+ patients are more likely to have multiple 
infections in the same eye which again reflects their compromised immune system. Thirdly, HIV+ 
patients are more likely to have non-anterior uveitis than anterior uveitis and this fits in with the 
theory that non-anterior uveitis is more frequently infectious in origin while anterior uveitis is more 
frequently non-infectious. An interesting finding relating to herpetic uveitis was the fact that all 
cases of herpetic anterior uveitis were PCR-/GWC+ and all cases of herpetic non-anterior uveitis 
were PCR+/GWC-. Furthermore, GWC+ anterior uveitis occurred almost equally between HIV+ and 
HIV- individuals while PCR+ non-anterior uveitis occurred much more frequently in HIV+ individuals. 
Even though the numbers are small this would seem to suggest that in cases with suspected herpetic 
anterior uveitis a GWC would be more likely to provide a positive result while in suspected herpetic 
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non-anterior uveitis PCR should be more likely to provide a positive result – especially if the patient 
is HIV+. 
Chapter 9 
Chapter 9 contains a summary of the epidemiological findings of this study which provided an 
affirmative answer to the original research question. The objectives outlined at the beginning of the 
study were met and are discussed in this chapter. In patients with anterior and panuveitis it was 
demonstrated that the causes were different between HIV+ and HIV- cases. It was determined that 
80% of HIV+ cases had infectious uveitis which illustrates the fact that clinicians should actively 
search for intraocular infections in all HIV+ cases as the majority of these respond well to 
antimicrobial therapy and poorly to corticosteroids alone. In contrast, only 5% of HIV+ cases had a 
non-infectious cause and 15% were idiopathic. In HIV- cases, 57.6% had an infectious cause while 
24.2% had non-infectious causes such as sarcoidosis. It is noteworthy that no cases of sarcoidosis or 
rubella virus were diagnosed in HIV+ individuals as these occurred exclusively in HIV- study 
participants. Another finding with clinical implications is that VZV was the most commonly identified 
herpes virus in both the HIV+ and HIV- groups as this differs from what has been reported from 
elsewhere in the world where CMV infection is more prevalent and has specific therapeutic 
requirements. 
Whilst it was not surprising to find that HIV+ patients had a high prevalence of infectious uveitis it 
was however remarkable to see how the patterns of infectious and non-infectious uveitis differed 
between HIV+ and HIV- patients. These differences were quantified for the very first time in our 
setting.  In other parts of the world an underlying cause of anterior uveitis is not found in the 
majority of cases whereas in our study idiopathic uveitis was only third on the list of causes in HIV+ 
patients and second on the list in HIV- individuals. Moreover, in cases with panuveitis, idiopathic 
uveitis did not even reach the top 3 in HIV+ patients and was only the third commonest cause in HIV- 
cases. This suggests that in both patients with and without HIV infection there is a high likelihood 
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that an underlying cause will be found, if a thorough investigation is conducted.  By identifying such 
an underlying cause clinicians should be able to treat the condition more effectively with ultimately 
a superior visual outcome for the patient.  
Chapter 10 
Chapter 10 explores the relationship between ocular and neurosyphilis by utilising traditional criteria 
as well as newer experimental methods. Neurosyphilis has been subdivided into confirmed and 
probable neurosyphilis for a number of years based on the results of certain CSF investigations – 
most specifically the CSF VDRL. More recently, it has been suggested that the diagnosis of probable 
neurosyphilis be based on slightly different criteria for HIV+ and HIV- individuals.16 This has led to 
some interesting findings regarding the diagnosis of neurosyphilis in a few of our patients. According 
to the CDC criteria for neurosyphilis, 4 patients required treatment for neurosyphilis but according 
to Marra’s algorithms on UpToDate a total of 6 patients should have been treated for neurosyphilis. 
The 2 additional patients were both HIV- and needed treatment based on raised CSF protein in one 
case and raised CSF WCC in the other. To make matters even more interesting, the immunoblot 
results suggested that a few more patients might have had neurosyphilis. In 2 cases, 1 HIV+ and 1 
HIV-, a diagnosis of neurosyphilis could not be made if both sets of criteria were strictly applied. The 
HIV+ case had 18 lymphocytes/µL instead of 20/µL and the HIV+ case had 5/µL instead of >5/µL so 
they could both be labelled near misses. However, if one adds the positive CSF immunoblot results 
and utilise our proposed algorithm then both of these patients had confirmed neurosyphilis. It 
therefore appears as if immunoblotting of CSF to look for treponemal proteins may provide 
additional information to help confirm a diagnosis of neurosyphilis – perhaps more so in borderline 
cases. 
To date, a diagnosis of ocular syphilis was based on positive blood serology and exclusion of other 
possible causes of uveitis. Identification of treponemal DNA or antibodies from the eye itself was 
therefore not required. Given the recent advances in diagnostic techniques we are of the opinion 
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that ocular syphilis should henceforth also be subdivided into confirmed and probable ocular syphilis 
based on the level of evidence obtained as outlined in our algorithm. Despite the disappointing 
results of our AH PCR, which should improve with further investigation, it was pleasing to 
demonstrate positive immunoblot results on AH in three cases which translates into a diagnosis of 
confirmed ocular syphilis. Immunoblotting therefore also appears to have a valuable role to play in 
distinguishing between confirmed and probable ocular syphilis and this role will become better 
defined as more research is conducted. 
Conclusion 
Addressing initial study objectives 
This study has enabled us to demonstrate differences in the causes of intraocular inflammation 
between HIV+ and HIV- patients in the Western Cape Province of South Africa. Specifically in Chapter 
9 we have presented the prevalence of all the causes of uveitis that were set out to achieve in the 
stated objectives. The secondary objectives have also been addressed by testing ocular and CSF 
samples of patients with positive blood serology for syphilis by PCR and immunoblotting and 
reporting on these in Chapter 10. Moreover, we have evaluated different types of investigations 
(radiological, serological, microbiological) to determine which tests are most useful in determining 
the etiology of infective uveitis. The results of the comparisons of different imaging techniques have 
not been presented in this dissertation as they will be published in the near future by some of our 
collaborators. 
Future research directions 
The majority of research in the near future will be focused on searching for, and also refining, new 
methods to accurately diagnose infectious causes of uveitis as these are by far the most prevalent in 
this setting. Biomarker analyses are already being performed on samples collected during the course 
of this study to determine whether characteristic patterns, or so-called bio-signatures, can be 
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identified to aid in the diagnosis of certain ocular infections. Attempts will be made to refine our 
syphilis PCR technique in order to improve its sensitivity. The syphilis immunoblot will also be 
studied further in order to better define both its role and value in clinical practice. Lastly, plans are 
underway to study the role of PCR with multiple targets such as MPB64, protein b and devR in 
addition to IS6110 to determine whether this approach could increase the sensitivity of TB PCR in 
accordance with what has already been published from elsewhere in the world.17,18 
What this study has contributed to Ophthalmology 
First and foremost, this study has quantified the prevalence of different causes of uveitis in the 
Western Cape Province which is something that was long overdue. We now have a much better 
understanding of what ophthalmologists are likely to encounter in a clinical setting from day to day 
and how to best go about confirming the diagnosis and prescribing the appropriate treatment. There 
are many areas that still require further investigation.  Secondly, the majority of the data generated 
by this study has either already been published in international journals or has at least been 
submitted for peer review – thereby sharing our newly found knowledge with researchers and 
clinicians from around the world who have shown great interest in wanting to know about our 
experience at the tip of Africa. Thirdly, apart from publishing the data, we have also shared with, and 
in the process learnt from, colleagues in other parts of the world via personal visits, the internet, 
Skype conferences and International Workshops/Congresses. Data has been presented orally at the 
Ophthalmological Society of South Africa’s annual congress in Port Elizabeth in 2017 and will be 
presented at the 14th Congress of the International Ocular Inflammation Society (IOIS) in Lausanne, 
Switzerland from 18 – 21 October 2017. 
During the course of this study we have evaluated different investigations used in the diagnosis of 
ocular TB in our highly endemic setting and either have already or will in the near future disseminate 
this knowledge to other interested parties. We have described rare cases, mostly involving patients 
with HIV infection, and provided feedback to researchers elsewhere about classification systems that 
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they have been revising. We took particular interest in the role played by EBV in causing uveitis and 
have produced solid evidence to question whether EBV really does cause intraocular inflammation. 
We have provided more data to define the role of PCR and GWC as diagnostic techniques against the 
background of a high prevalence of HIV infection and we have introduced the idea of using 
immunoblotting as an additional diagnostic modality to study the relationship between ocular and 
neurosyphilis and, in so doing, have suggested that ocular syphilis should henceforth also be 
subdivided in a similar fashion to neurosyphilis. 
Overarching conclusion 
In South Africa, with its high prevalence of HIV infection, TB and other infectious diseases, most 
cases of intraocular inflammation are caused by underlying infections in both HIV+ and HIV- patients. 
It is therefore of utmost importance that clinicians dealing with these patients have a detailed 
understanding of what they are likely to encounter in order to accurately and cost-effectively 
diagnose these conditions and provide the best possible treatment. In this study we have 
established the patterns of uveitis in our immediate surroundings, we have evaluated existing 
diagnostic techniques and classifications and we have introduced novel techniques and proposed 
alterations to current classifications after applying these techniques. Based on these findings we 
have designed an algorithm that summarizes our current approach to uveitis cases (Figure 1; 
https://www.dropbox.com/s/qwjy5jmxaj0xf50/Algorithm.xlsx?dl=0).   In the process we have gained 
a deeper understanding of how best to manage patients with potentially vision-threatening diseases. 
The good news is that, in contrast to other parts of the world where many cases of uveitis remain 
idiopathic, we have identified an underlying cause of inflammation in 83% of cases we studied and 
were therefore able to provide targeted rather than empiric treatment to those patients. We should, 
and we will, continue searching for answers to questions that currently have none until we reach the 
day when we can confidently say that uveitis is idiopathic no more.  
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